Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyBiologicalProcess	bleb assembly	MYLK ANLN ANO6	2.08e-05	13	88	3	GO:0032060
GeneOntologyBiologicalProcess	intermediate filament cytoskeleton organization	KRT1 KRT82 ATP8A2 MACF1 EVPL	6.58e-05	99	88	5	GO:0045104
GeneOntologyBiologicalProcess	intermediate filament-based process	KRT1 KRT82 ATP8A2 MACF1 EVPL	6.90e-05	100	88	5	GO:0045103
HumanPheno	Prolonged QT interval	BPTF AKAP9 KCNH2 SVIL MECP2	1.80e-05	54	32	5	HP:0001657
HumanPheno	Prolonged QTc interval	AKAP9 KCNH2 SVIL MECP2	2.73e-05	29	32	4	HP:0005184
HumanPheno	Abnormal QT interval	BPTF AKAP9 KCNH2 SVIL MECP2	4.14e-05	64	32	5	HP:0031547
Domain	EF_HAND_1	EFCAB5 CALU EFCAB13 DGKB MACF1 LCP1 NCS1 ADGRL4	6.36e-06	204	90	8	PS00018
Domain	-	EFCAB5 CALU EFCAB13 DGKB MACF1 LCP1 UTRN NCS1	3.77e-05	261	90	8	1.10.238.10
Domain	EF-hand-dom_pair	EFCAB5 CALU EFCAB13 DGKB MACF1 LCP1 UTRN NCS1	7.35e-05	287	90	8	IPR011992
Domain	EF_HAND_2	EFCAB5 CALU EFCAB13 DGKB MACF1 LCP1 NCS1	1.26e-04	231	90	7	PS50222
Domain	EF_hand_dom	EFCAB5 CALU DGKB MACF1 LCP1 NCS1 ADGRL4	1.30e-04	232	90	7	IPR002048
Domain	Actinin_actin-bd_CS	MACF1 LCP1 UTRN	1.79e-04	23	90	3	IPR001589
Domain	ACTININ_2	MACF1 LCP1 UTRN	1.79e-04	23	90	3	PS00020
Domain	ACTININ_1	MACF1 LCP1 UTRN	1.79e-04	23	90	3	PS00019
Domain	EF_Hand_1_Ca_BS	EFCAB5 CALU DGKB MACF1 LCP1 NCS1	2.02e-04	175	90	6	IPR018247
Domain	-	MACF1 EVPL	3.40e-04	6	90	2	3.90.1290.10
Domain	Spectrin_repeat	MACF1 EVPL UTRN	3.61e-04	29	90	3	IPR002017
Domain	Plectin_repeat	MACF1 EVPL	4.75e-04	7	90	2	IPR001101
Domain	Plectin	MACF1 EVPL	4.75e-04	7	90	2	PF00681
Domain	PLEC	MACF1 EVPL	4.75e-04	7	90	2	SM00250
Domain	Spectrin/alpha-actinin	MACF1 EVPL UTRN	4.85e-04	32	90	3	IPR018159
Domain	SPEC	MACF1 EVPL UTRN	4.85e-04	32	90	3	SM00150
Domain	EF-hand_7	DGKB MACF1 LCP1 NCS1	7.58e-04	85	90	4	PF13499
Domain	EF-hand_1	CALU DGKB MACF1 LCP1 NCS1	8.43e-04	152	90	5	PF00036
Domain	EFh	CALU DGKB MACF1 LCP1 NCS1	1.00e-03	158	90	5	SM00054
Domain	CAP_GLY	CLIP4 DCTN1	1.01e-03	10	90	2	PF01302
Domain	CAP_GLY_1	CLIP4 DCTN1	1.01e-03	10	90	2	PS00845
Domain	CAP_GLY_2	CLIP4 DCTN1	1.01e-03	10	90	2	PS50245
Domain	CAP-Gly_domain	CLIP4 DCTN1	1.01e-03	10	90	2	IPR000938
Domain	CAP_GLY	CLIP4 DCTN1	1.01e-03	10	90	2	SM01052
Domain	-	CLIP4 DCTN1	1.01e-03	10	90	2	2.30.30.190
Domain	FN3	FNDC1 MYLK OBSCN CMYA5 IFNAR1	2.01e-03	185	90	5	SM00060
Domain	AT_hook	CECR2 MECP2	2.64e-03	16	90	2	PF02178
Domain	FN3	FNDC1 MYLK OBSCN CMYA5 IFNAR1	2.76e-03	199	90	5	PS50853
Domain	FN3_dom	FNDC1 MYLK OBSCN CMYA5 IFNAR1	3.41e-03	209	90	5	IPR003961
Domain	CH	MACF1 LCP1 UTRN	3.81e-03	65	90	3	SM00033
Domain	Apc4_WD40_dom	EML5 COPA	4.12e-03	20	90	2	IPR024977
Domain	ANAPC4_WD40	EML5 COPA	4.12e-03	20	90	2	PF12894
Domain	CH	MACF1 LCP1 UTRN	4.69e-03	70	90	3	PF00307
Pubmed	Human transcription factor protein interaction networks.	BPTF TSHZ3 SLK ARID1B SMG7 ALMS1 COPA MRPL12 CALU PRRC2C ZNF644 HSPH1 SVIL MSANTD2 OTUD4 ZFR PATL1 GPATCH8 PFKP ZMYM3 RAD21	1.17e-10	1429	92	21	35140242
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	BPTF MYOF LATS1 WASHC2C COPA ANLN ZC3H13 ZNF644 SVIL FNBP4 OTUD4 PATL1 GPATCH8 PFKP MECP2 ZMYM3	2.03e-10	774	92	16	15302935
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	TICRR ARID1B POLR3D WASHC2C EML5 ANLN ZC3H13 TTLL4 HSPH1 OBSCN OTUD4 MACF1 HEATR1 PATL1 GPATCH8 DCTN1 UTRN ITPR1	4.47e-10	1084	92	18	11544199
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SLK AKAP9 WASHC2C ACOT11 PRRC2C ZNF644 ARHGEF12 OTUD4 DGKB MACF1 GPATCH8 ZMYM3	8.77e-10	407	92	12	12693553
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	ARID1B WASHC2C COPA MRPL12 KCTD5 ANLN CALU ZNF644 SVIL EIF3K ZFR PATL1 CDCA8 DCTN1 ZMYM3 FBXO30 ITPR1 RAD21	1.22e-09	1155	92	18	20360068
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	BPTF SLK ARID1B LATS1 SMG7 ALMS1 ANLN PRRC2C FNBP4 ZFR HEATR1 SMC2 DCTN1	2.35e-09	549	92	13	38280479
Pubmed	N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.	BPTF SLK GSPT2 ANLN PRRC2C SVIL MACF1 EVPL ZFR CHD1L UTRN	3.19e-09	360	92	11	33111431
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	EFCAB5 KRT1 BPTF ELOA2 LATS1 GSPT2 MYLK COPA PRRC2C PCLO HSPH1 MACF1 ZFR HEATR1 PFKP SMC2 LCP1 DCTN1 MECP2	6.19e-09	1442	92	19	35575683
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	BPTF COPA PRRC2C POLE ZC3H13 MACF1 ZFR HEATR1 PFKP LCP1 UTRN ZMYM3 RAD21	1.84e-08	653	92	13	22586326
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	KRT1 MYOF COPA ANLN UTP11 PRRC2C RBM19 ZC3H13 HSPH1 SVIL EVPL ZFR HEATR1 PFKP SMC2 MECP2 RAD21	3.00e-08	1257	92	17	36526897
Pubmed	Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.	KRT1 SLK GSPT2 COPA MRPL12 PRRC2C RBM19 HSPH1 FNBP4 EIF3K MACF1 UCK2 PATL1 PFKP SMC2 DCTN1 RAD21	1.63e-07	1415	92	17	28515276
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	SLK WASHC2C SMG7 ALMS1 MRPL12 PRRC2C HSPH1 MACF1 ZFR HEATR1 PFKP DCTN1 UTRN RAD21	1.66e-07	934	92	14	33916271
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	BPTF ARID1B ANLN UTP11 PRRC2C RBM19 ZC3H13 ZNF644 FNBP4 ZFR HEATR1 CDCA8 MECP2 RAD21	2.15e-07	954	92	14	36373674
Pubmed	Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking.	BPTF WASHC2C COPA ANLN GPATCH8 PFKP SMC2 ZMYM3 RAD21	2.56e-07	332	92	9	32786267
Pubmed	Tumor suppressor BAP1 nuclear import is governed by transportin-1.	KRT1 SLK COPA MRPL12 CALU PRRC2C HSPH1 SVIL OTUD4 EIF3K MACF1 PFKP SMC2 LCP1 DCTN1	3.38e-07	1149	92	15	35446349
Pubmed	Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis.	SLK COPA MRPL12 PRRC2C ZC3H13 HSPH1 MACF1 ZFR PFKP SMC2 LCP1 DCTN1 UTRN	3.67e-07	847	92	13	35235311
Pubmed	Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells.	MYOF SLK COPA MRPL12 ANLN ANO6 CALU CFAP36 RBM19 HSPH1 ZFR PFKP SMC2 DCTN1 UTRN RAD21	5.61e-07	1367	92	16	32687490
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	BPTF TSHZ3 ANLN ZNF644 CHD1L GPATCH8 CDCA8 MECP2 ZMYM3 DNMT3A RAD21	6.37e-07	608	92	11	36089195
Pubmed	Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.	MYOF SLK LATS1 AKAP9 MYLK ANLN HSPH1 EIF3K GPATCH8 CDCA8 DCTN1 UTRN NCS1	8.21e-07	910	92	13	36736316
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	BPTF ARID1B ANLN CALU PRRC2C ZNF644 HSPH1 MSANTD2 ZFR SMC2 LCP1 MECP2 ZMYM3 RAD21	1.21e-06	1103	92	14	34189442
Pubmed	PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation.	KRT1 SMG7 MRPL12 KCTD5 PRRC2C KRT82 RBM19 HSPH1 OTUD4 ZFR PATL1	1.83e-06	678	92	11	30209976
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	MYOF MRPL12 ANLN RBM19 HSPH1 ARHGEF12 OTUD4 EIF3K MACF1 HEATR1 GPATCH8 PFKP UTRN MECP2 ZMYM3 RAD21	1.84e-06	1497	92	16	31527615
Pubmed	Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer.	WASHC2C MRPL12 CALU ZC3H13 FNBP4 EVPL ZFR HEATR1 SMC2 DCTN1 ZMYM3 RAD21	2.46e-06	847	92	12	35850772
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	COPA ANLN RBM19 POLE HSPH1 PPP1R37 MACF1 ZFR CHD1L HEATR1 PFKP SMC2 DCTN1 UTRN ZMYM3	2.58e-06	1353	92	15	29467282
Pubmed	Elucidation of the BMI1 interactome identifies novel regulatory roles in glioblastoma.	MYOF POLR3D AKAP9 KCNH2 PRRC2C EIF3K EVPL PFKP	2.75e-06	329	92	8	34316702
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	BPTF COPA PRRC2C POLE ZNF644 ZFR CHD1L HEATR1 SMC2 DCTN1 MECP2 ZMYM3	2.77e-06	857	92	12	25609649
Pubmed	Expanding the Interactome of TES by Exploiting TES Modules with Different Subcellular Localizations.	MYOF COPA CALU SVIL MACF1 DCTN1 UTRN	3.16e-06	235	92	7	28378594
Pubmed	Disrupted in Schizophrenia 1 Interactome: evidence for the close connectivity of risk genes and a potential synaptic basis for schizophrenia.	AKAP9 MACF1 SMC2 DCTN1 UTRN RAD21	3.18e-06	151	92	6	17043677
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	MYOF SLK SMG7 COPA PRRC2C RBM19 HSPH1 OTUD4 MACF1 ZFR PATL1	3.44e-06	724	92	11	36232890
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	BPTF ALMS1 PRRC2C POLE CECR2 EIF3K SMC2 MECP2 RAD21	4.41e-06	469	92	9	27634302
Pubmed	A novel role for the peptidyl-prolyl cis-trans isomerase Cyclophilin A in DNA-repair following replication fork stalling via the MRE11-RAD50-NBS1 complex.	BPTF ARID1B ANLN MACF1 HEATR1 SMC2 CDCA8 MECP2 FBXO30	4.64e-06	472	92	9	38943005
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	KRT1 SLK COPA PRRC2C PCLO HSPH1 SVIL ARHGEF12 OTUD4 DGKB MACF1 PFKP DCTN1 UTRN MECP2	5.08e-06	1431	92	15	37142655
Pubmed	The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.	BPTF TICRR COPA PRRC2C POLE MACF1 ZFR HEATR1 SMC2 CDCA8 RAD21	5.38e-06	759	92	11	35915203
Pubmed	MeCP2 Represses Enhancers through Chromosome Topology-Associated DNA Methylation.	MECP2 DNMT3A	6.92e-06	2	92	2	31784360
Pubmed	MeCP2 Represses the Rate of Transcriptional Initiation of Highly Methylated Long Genes.	MECP2 DNMT3A	6.92e-06	2	92	2	31784358
Pubmed	Neuronal calcium sensor-1 enhancement of InsP3 receptor activity is inhibited by therapeutic levels of lithium.	NCS1 ITPR1	6.92e-06	2	92	2	16691292
Pubmed	Ste20-like protein kinase SLK (LOSK) regulates microtubule organization by targeting dynactin to the centrosome.	SLK DCTN1	6.92e-06	2	92	2	23985322
Pubmed	DNA methylation in the gene body influences MeCP2-mediated gene repression.	MECP2 DNMT3A	6.92e-06	2	92	2	27965390
Pubmed	Disruption of DNA-methylation-dependent long gene repression in Rett syndrome.	MECP2 DNMT3A	6.92e-06	2	92	2	25762136
Pubmed	Chromatin-dependent allosteric regulation of DNMT3A activity by MeCP2.	MECP2 DNMT3A	6.92e-06	2	92	2	30102379
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	CLIP4 ARID1B AKAP9 ALMS1 OBSCN MACF1 CMYA5 DCTN1 UTRN	7.03e-06	497	92	9	23414517
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	ACTL7A BPTF ARID1B EML5 SMG7 ALMS1 CALU CFAP36 CECR2 MACF1 UCK2 MECP2 ZMYM3	7.62e-06	1116	92	13	31753913
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	BPTF TICRR COPA ZC3H13 ZNF644 FNBP4 ZFR CHD1L HEATR1 GPATCH8 SMC2 MECP2 ZMYM3 RAD21	7.62e-06	1294	92	14	30804502
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	AKAP9 MRPL12 ANO6 CALU POLE ZC3H13 ZNF644 HSPH1 FNBP4 MACF1 HEATR1 PFKP DCTN1 ITPR1 RAD21	8.04e-06	1487	92	15	33957083
Pubmed	The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.	GSPT2 UTP11 PRRC2C RBM19 ZC3H13 OTUD4 MACF1 ZFR HEATR1 PATL1 GPATCH8	9.56e-06	807	92	11	22681889
Pubmed	In silico APC/C substrate discovery reveals cell cycle-dependent degradation of UHRF1 and other chromatin regulators.	FNDC1 COPA MRPL12 KCTD5 UTP11 PRRC2C HSPH1 ARHGEF12 EIF3K ZFR SMC2 DCTN1	9.79e-06	971	92	12	33306668
Pubmed	The SOX2-interactome in brain cancer cells identifies the requirement of MSI2 and USP9X for the growth of brain tumor cells.	TSHZ3 MRPL12 KCTD5 ZNF644 MACF1 PFKP SMC2	1.04e-05	282	92	7	23667531
Pubmed	Kelch Domain of Gigaxonin Interacts with Intermediate Filament Proteins Affected in Giant Axonal Neuropathy.	KRT1 ALMS1 KCTD5 KRT82 ZC3H13 ARHGEF12	1.08e-05	187	92	6	26460568
Pubmed	The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1.	ZC3H13 HSPH1 MACF1 GPATCH8 UTRN MECP2	1.46e-05	197	92	6	20811636
Pubmed	USP7 Regulates Cytokinesis through FBXO38 and KIF20B.	TICRR TSHZ3 POLE ZNF644 GPATCH8	1.48e-05	116	92	5	30804394
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	BPTF COPA KRT82 SVIL MACF1 UCK2 ZFR HEATR1 PFKP SMC2 CDCA8 UTRN	1.66e-05	1024	92	12	24711643
Pubmed	ATG5 is required for B cell polarization and presentation of particulate antigens.	COPA CALU PRRC2C ZC3H13 FNBP4 GPATCH8 PFKP SMC2 LCP1 ITPR1	1.69e-05	701	92	10	30196744
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	VPS13D LATS1 AKAP9 ALMS1 ANLN CALU PRRC2C SVIL MACF1 PFKP UTRN	1.74e-05	861	92	11	36931259
Pubmed	E-cadherin interactome complexity and robustness resolved by quantitative proteomics.	SLK ANLN SVIL PPP1R37 ARHGEF12 MACF1 EVPL PFKP UTRN	1.94e-05	565	92	9	25468996
Pubmed	CHD1L prevents lipopolysaccharide-induced hepatocellular carcinomar cell death by activating hnRNP A2/B1-nmMYLK axis.	MYLK CHD1L	2.07e-05	3	92	2	34588420
Pubmed	Supervillin binding to myosin II and synergism with anillin are required for cytokinesis.	ANLN SVIL	2.07e-05	3	92	2	24088567
Pubmed	CECR2, a protein involved in neurulation, forms a novel chromatin remodeling complex with SNF2L.	BPTF CECR2	2.07e-05	3	92	2	15640247
Pubmed	Stimulus-dependent regulation of nuclear Ca2+ signaling in cardiomyocytes: a role of neuronal calcium sensor-1.	NCS1 ITPR1	2.07e-05	3	92	2	25897502
Pubmed	Losing Dnmt3a dependent methylation in inhibitory neurons impairs neural function by a mechanism impacting Rett syndrome.	MECP2 DNMT3A	2.07e-05	3	92	2	32159514
Pubmed	Molecular basis of functional exchangeability between ezrin and other actin-membrane associated proteins during cytokinesis.	ANLN SVIL	2.07e-05	3	92	2	33862101
Pubmed	Prohibitin 1 regulates tumor cell apoptosis via the interaction with X-linked inhibitor of apoptosis protein.	KRT1 COPA MRPL12 PRRC2C POLE HSPH1 UCK2 ZFR PATL1 SMC2	2.26e-05	725	92	10	27025967
Pubmed	BioID Performed on Golgi Enriched Fractions Identify C10orf76 as a GBF1 Binding Protein Essential for Golgi Maintenance and Secretion.	MYOF SLK PRRC2C HSPH1 PATL1 DCTN1	2.45e-05	216	92	6	31519766
Pubmed	Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.	COPA ANLN POLE MACF1 CHD1L PFKP SMC2 DCTN1 RAD21	2.45e-05	582	92	9	20467437
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	MYOF LATS1 GSPT2 AKAP9 COPA CALU HSPH1 SVIL OTUD4 PATL1 PFKP SMC2 DCTN1	2.45e-05	1247	92	13	27684187
Pubmed	Protein-protein interactions between large proteins: two-hybrid screening using a functionally classified library composed of long cDNAs.	VPS13D SLK ALMS1 FNBP4 MACF1	2.56e-05	130	92	5	12421765
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	TICRR ZC3H13 PCLO HSPH1 OBSCN EVPL CFAP57 PFKP UTRN CCDC39	2.57e-05	736	92	10	29676528
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	KRT1 BPTF ARID1B COPA CECR2 ZC3H13 FNBP4 MACF1 GPATCH8 MECP2 ZMYM3 DNMT3A	2.85e-05	1082	92	12	38697112
Pubmed	Global landscape of HIV-human protein complexes.	AKAP9 ALMS1 CALU POLE HSPH1 ARHGEF12 EIF3K HEATR1	2.97e-05	457	92	8	22190034
Pubmed	Tagging genes with cassette-exchange sites.	BPTF MRPL12 PRRC2C PPP1R37 ARHGEF12 MACF1 GPATCH8	3.14e-05	335	92	7	15741177
Pubmed	BioID-based Identification of Skp Cullin F-box (SCF)β-TrCP1/2 E3 Ligase Substrates.	SMG7 ALMS1 MRPL12 RBM19 ZFR GPATCH8	3.15e-05	226	92	6	25900982
Pubmed	A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase.	EML5 SMG7 RBM19 POLE ZNF644 ZFR	3.65e-05	232	92	6	25515538
Pubmed	A High-Density Human Mitochondrial Proximity Interaction Network.	VPS13D AKAP9 ALMS1 COPA MRPL12 UTP11 CFAP36 POLE ZNF644 PCLO ZFR HEATR1 ITPR1 RAD21	3.80e-05	1496	92	14	32877691
Pubmed	Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.	WASHC2C COPA PRRC2C ARHGEF12 OTUD4 ZFR ITPR1 RAD21	3.90e-05	475	92	8	31040226
Pubmed	Cigarette smoke induces proteasomal-mediated degradation of DNA methyltransferases and methyl CpG-/CpG domain-binding proteins in embryonic orofacial cells.	MECP2 DNMT3A	4.14e-05	4	92	2	26482727
Pubmed	Exome sequencing in seven families and gene-based association studies indicate genetic heterogeneity and suggest possible candidates for fibromuscular dysplasia.	MYLK OBSCN	4.14e-05	4	92	2	26147384
Pubmed	Complete Structure of an Epithelial Keratin Dimer: Implications for Intermediate Filament Assembly.	KRT1 KRT82	4.14e-05	4	92	2	26181054
Pubmed	TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1.	KRT1 GSPT2 COPA UTP11 HSPH1 SVIL ZFR HEATR1 PFKP DCTN1 ITPR1	4.23e-05	949	92	11	36574265
Pubmed	RAD21 cooperates with pluripotency transcription factors in the maintenance of embryonic stem cell identity.	KRT1 PFKP FBXO30 DNMT3A RAD21	4.46e-05	146	92	5	21589869
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	SLK AKAP9 PRRC2C SVIL ARHGEF12 MSANTD2 OTUD4 MACF1 ZFR SMC2 DCTN1	4.83e-05	963	92	11	28671696
Pubmed	Destabilization of Atoh1 by E3 Ubiquitin Ligase Huwe1 and Casein Kinase 1 Is Essential for Normal Sensory Hair Cell Development.	AKAP9 PRRC2C MACF1 UTRN	5.08e-05	76	92	4	27542412
Pubmed	The HIV-1 Tat protein recruits a ubiquitin ligase to reorganize the 7SK snRNP for transcriptional activation.	KRT1 ARID1B SMG7 COPA MRPL12 HSPH1 EIF3K MACF1 ZFR SMC2 LCP1 DCTN1	5.26e-05	1153	92	12	29845934
Pubmed	Cullin 1 (CUL1) Promotes Primary Ciliogenesis through the Induction of Ubiquitin-Proteasome-Dependent Dvl2 Degradation.	KRT1 AKAP9 EML5 MACF1 GPATCH8	5.40e-05	152	92	5	34299191
Pubmed	Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.	SLK ALMS1 ANLN CHD1L LCP1 CDCA8 UTRN MECP2 DNMT3A	5.43e-05	645	92	9	25281560
Pubmed	Proteomic and Biochemical Comparison of the Cellular Interaction Partners of Human VPS33A and VPS33B.	WASHC2C SMG7 POLE ARHGEF12 PFKP FBXO30	5.65e-05	251	92	6	29778605
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	WASHC2C COPA ANLN CALU ZC3H13 HSPH1 OTUD4 PFKP	5.82e-05	503	92	8	16964243
Pubmed	Defining the membrane proteome of NK cells.	KRT1 COPA ANO6 CALU PRRC2C RBM19 EIF3K HEATR1 PFKP DCTN1 ITPR1 RAD21	5.95e-05	1168	92	12	19946888
Pubmed	Nuclear actin interactome analysis links actin to KAT14 histone acetyl transferase and mRNA splicing.	MRPL12 ANLN FNBP4 ZFR LCP1 DCTN1 UTRN FBXO30	6.07e-05	506	92	8	30890647
Pubmed	MYC multimers shield stalled replication forks from RNA polymerase.	BPTF COPA ANLN CALU UTP11 RBM19 HSPH1 ZFR HEATR1 GPATCH8 RAD21	6.13e-05	989	92	11	36424410
Pubmed	The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch.	MYOF SLK ANLN PRRC2C HSPH1 HEATR1	6.30e-05	256	92	6	33397691
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	KRT1 AKAP9 COPA PRRC2C RBM19 HSPH1 SVIL FNBP4 OTUD4 CHD1L PATL1 MECP2 FBXO30	6.48e-05	1371	92	13	36244648
Pubmed	An Activity-Mediated Transition in Transcription in Early Postnatal Neurons.	MECP2 DNMT3A	6.89e-05	5	92	2	32589877
Pubmed	miR-218 Promotes Dopaminergic Differentiation and Controls Neuron Excitability and Neurotransmitter Release through the Regulation of a Synaptic-Related Genes Network.	PCLO MECP2 DNMT3A	7.63e-05	31	92	3	37816598
Pubmed	Large-scale proteomics and phosphoproteomics of urinary exosomes.	MYOF VPS13D SLK EML5 ACOT11 ANO6 ARHGEF12 EVPL SMC2 LCP1 UTRN	7.78e-05	1016	92	11	19056867
Pubmed	Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing.	BPTF MRPL12 ANLN ZFR SMC2 RAD21	8.62e-05	271	92	6	32433965
Pubmed	HectD1 controls hematopoietic stem cell regeneration by coordinating ribosome assembly and protein synthesis.	COPA HSPH1 SMC2 UTRN	8.63e-05	87	92	4	33711283
Pubmed	The variant Polycomb Repressor Complex 1 component PCGF1 interacts with a pluripotency sub-network that includes DPPA4, a regulator of embryogenesis.	BPTF ARID1B AKAP9 COPA CECR2 PCLO GPATCH8	8.98e-05	396	92	7	26687479
Pubmed	Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette.	BPTF VPS13D MRPL12 TTLL4 SVIL FNBP4 CHD1L ITPR1	9.05e-05	536	92	8	15840001
Pubmed	Exchangeable gene trap using the Cre/mutated lox system.	BPTF VPS13D MRPL12 TTLL4 SVIL FNBP4 CHD1L ITPR1	9.29e-05	538	92	8	10512203
Pubmed	Optimized fragmentation schemes and data analysis strategies for proteome-wide cross-link identification.	WASHC2C HSPH1 OTUD4 MACF1 CHD1L PFKP SMC2 UTRN	9.29e-05	538	92	8	28524877
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	SLK COPA CALU RBM19 POLE PCLO HSPH1 ZFR HEATR1 CMYA5 SMC2 DCTN1 RAD21	9.55e-05	1425	92	13	30948266
Interaction	WWTR1 interactions	BPTF SLK ARID1B LATS1 SMG7 ALMS1 ANLN PRRC2C HEATR1 SMC2 DCTN1	3.14e-06	422	91	11	int:WWTR1
Interaction	ZNF330 interactions	ANLN RBM19 POLE ZNF644 HEATR1 GPATCH8 CDCA8 MECP2 ZMYM3 DNMT3A RAD21	5.31e-06	446	91	11	int:ZNF330
Interaction	RDX interactions	GSPT2 MRPL12 ANLN CALU HSPH1 SVIL MACF1 LCP1 UTRN	5.51e-06	284	91	9	int:RDX
Interaction	CENPA interactions	BPTF TSHZ3 POLE ZC3H13 ZNF644 CDCA8 MECP2 ZMYM3 DNMT3A RAD21	7.79e-06	377	91	10	int:CENPA
Interaction	NANOG interactions	KRT1 BPTF ARID1B AKAP9 CECR2 ZFR GPATCH8 PFKP FBXO30 DNMT3A RAD21	1.08e-05	481	91	11	int:NANOG
Interaction	POLR1G interactions	BPTF POLR3D RBM19 ZNF644 HEATR1 PFKP CDCA8 MECP2 ZMYM3 DNMT3A RAD21	1.26e-05	489	91	11	int:POLR1G
Interaction	H2BC21 interactions	BPTF TICRR ARID1B ZNF644 PCLO SVIL FNBP4 OBSCN CHD1L SMC2 CDCA8 MECP2 ZMYM3	1.43e-05	696	91	13	int:H2BC21
Interaction	CHD4 interactions	KRT1 BPTF TSHZ3 SLK PRRC2C RBM19 ZNF644 FNBP4 ZFR GPATCH8 SMC2 DCTN1 MECP2 ZMYM3 RAD21	1.86e-05	938	91	15	int:CHD4
Interaction	GAN interactions	KRT1 ALMS1 KCTD5 ANLN KRT82 ZC3H13 ARHGEF12 ZMYM3	1.91e-05	253	91	8	int:GAN
Interaction	TES interactions	ACTL7A MYOF COPA ANLN CALU SVIL MACF1 DCTN1 UTRN	1.92e-05	332	91	9	int:TES
Interaction	ALG13 interactions	ARID1B LATS1 SMG7 PRRC2C OTUD4 ZFR GPATCH8	1.93e-05	183	91	7	int:ALG13
Interaction	PARP1 interactions	BPTF MYOF ANLN RBM19 POLE CECR2 ZNF644 SVIL MSANTD2 OTUD4 CHD1L HEATR1 SMC2 CDCA8 MECP2 ZMYM3 DNMT3A RAD21	2.04e-05	1316	91	18	int:PARP1
Interaction	CIT interactions	BPTF AKAP9 ALMS1 COPA ANLN CALU PRRC2C RBM19 ZC3H13 PCLO SVIL MACF1 ZFR HEATR1 CMYA5 PFKP CDCA8 DCTN1 RAD21	2.10e-05	1450	91	19	int:CIT
Interaction	SIRT7 interactions	BPTF COPA PRRC2C POLE ZC3H13 MACF1 ZFR HEATR1 PFKP LCP1 UTRN ZMYM3 RAD21	2.87e-05	744	91	13	int:SIRT7
Interaction	KRT8 interactions	KRT1 AKAP9 SMG7 ALMS1 ANLN ARHGEF12 OTUD4 PATL1 DCTN1 MECP2	3.01e-05	441	91	10	int:KRT8
Interaction	NAA40 interactions	SLK WASHC2C SMG7 ALMS1 MRPL12 PRRC2C HSPH1 MACF1 ZFR HEATR1 PFKP DCTN1 UTRN MECP2 RAD21	3.02e-05	978	91	15	int:NAA40
Interaction	FOXB1 interactions	COPA POLE ZFR CHD1L HEATR1 SMC2	3.38e-05	135	91	6	int:FOXB1
Interaction	CEBPA interactions	BPTF ARID1B AKAP9 ANLN CALU PRRC2C ZNF644 HSPH1 MSANTD2 MACF1 ZFR SMC2 LCP1 MECP2 ZMYM3 RAD21 MAF	3.68e-05	1245	91	17	int:CEBPA
Interaction	FOXQ1 interactions	COPA POLE ZFR HEATR1 SMC2 ZMYM3	4.31e-05	141	91	6	int:FOXQ1
Interaction	CPEB1 interactions	SMG7 PRRC2C HSPH1 OTUD4 ZFR PATL1	5.24e-05	146	91	6	int:CPEB1
Interaction	DNAJC9 interactions	LATS1 ANLN ZC3H13 HSPH1 FNBP4 HEATR1 PFKP RAD21	5.83e-05	296	91	8	int:DNAJC9
Interaction	EGLN3 interactions	TICRR SMG7 COPA KCTD5 CALU POLE ZNF644 TTLL4 HSPH1 OTUD4 CHD1L PATL1 GPATCH8 SMC2 DCTN1 UTRN FBXO30	6.08e-05	1296	91	17	int:EGLN3
Interaction	CPEB4 interactions	KRT1 SMG7 PRRC2C OTUD4 PATL1 MECP2	7.57e-05	156	91	6	int:CPEB4
Interaction	MYH3 interactions	CLIP4 LATS1 ANLN CDCA8	8.92e-05	52	91	4	int:MYH3
Interaction	SMC3 interactions	MYOF AKAP9 MRPL12 ANLN ARHGEF12 OTUD4 SMC2 MECP2 RAD21	9.48e-05	408	91	9	int:SMC3
Interaction	YWHAH interactions	TICRR VPS13D LATS1 AKAP9 ALMS1 ANLN KCNH2 PRRC2C ZC3H13 HSPH1 SVIL MACF1 DCTN1 UTRN CCDC39	1.17e-04	1102	91	15	int:YWHAH
Interaction	NUP43 interactions	BPTF ARID1B PRRC2C RBM19 ZC3H13 ZNF644 HEATR1 GPATCH8 CDCA8 MECP2 ZMYM3	1.17e-04	625	91	11	int:NUP43
Interaction	KLF8 interactions	BPTF CALU PRRC2C ZNF644 HSPH1 MSANTD2 ZMYM3 RAD21	1.21e-04	329	91	8	int:KLF8
Interaction	MYCN interactions	KRT1 ARID1B POLR3D GSPT2 MRPL12 CALU UTP11 PRRC2C RBM19 ZC3H13 HSPH1 ZFR GPATCH8 SMC2 MECP2 ZMYM3 DNMT3A	1.23e-04	1373	91	17	int:MYCN
Interaction	HECTD1 interactions	BPTF TICRR COPA PRRC2C POLE HSPH1 MACF1 ZFR HEATR1 SMC2 CDCA8 DCTN1 UTRN RAD21	1.27e-04	984	91	14	int:HECTD1
Interaction	HDAC2 interactions	KRT1 BPTF COPA MRPL12 PRRC2C ZNF644 PFKP SMC2 DCTN1 MECP2 ZMYM3 RAD21 MAF	1.33e-04	865	91	13	int:HDAC2
Interaction	YWHAG interactions	TICRR VPS13D SLK LATS1 AKAP9 ALMS1 ANLN PRRC2C ZC3H13 HSPH1 SVIL MACF1 PFKP UTRN ZMYM3 NCS1	1.35e-04	1248	91	16	int:YWHAG
Interaction	CYLD interactions	KRT1 MYOF ALMS1 COPA MRPL12 KCTD5 PRRC2C CECR2 HSPH1 ARHGEF12 OTUD4 EIF3K DCTN1	1.37e-04	868	91	13	int:CYLD
Interaction	FBL interactions	LATS1 SMG7 ANLN UTP11 PRRC2C RBM19 ZNF644 OTUD4 ZFR HEATR1 MECP2	1.42e-04	639	91	11	int:FBL
Interaction	SMC5 interactions	BPTF ARID1B ANLN UTP11 PRRC2C RBM19 ZC3H13 ZNF644 FNBP4 ZFR HEATR1 CDCA8 MECP2 RAD21	1.51e-04	1000	91	14	int:SMC5
Interaction	MTA2 interactions	BPTF LATS1 ANLN PFKP SMC2 DCTN1 MECP2 ZMYM3 RAD21	1.54e-04	435	91	9	int:MTA2
Interaction	CBX3 interactions	MRPL12 ANLN ZC3H13 ZNF644 MSANTD2 MACF1 CHD1L HEATR1 CDCA8 MECP2 ZMYM3	1.56e-04	646	91	11	int:CBX3
Interaction	CDH1 interactions	KRT1 SLK ANLN SVIL PPP1R37 ARHGEF12 MACF1 EVPL PFKP CDCA8 UTRN DNMT3A	1.72e-04	768	91	12	int:CDH1
Interaction	LSM14A interactions	SMG7 MRPL12 ANLN PRRC2C OTUD4 ZFR PATL1	1.77e-04	260	91	7	int:LSM14A
Interaction	GOLGA1 interactions	WASHC2C SMG7 ALMS1 PPP1R37 ARHGEF12 MACF1	1.82e-04	183	91	6	int:GOLGA1
Interaction	SOX2 interactions	BPTF TSHZ3 ARID1B COPA MRPL12 KCTD5 ZNF644 MACF1 EVPL ZFR HEATR1 PFKP SMC2 LCP1 MECP2 TGM5 RAD21	1.88e-04	1422	91	17	int:SOX2
Interaction	EZR interactions	MYLK MRPL12 ANLN HSPH1 SVIL ARHGEF12 MACF1 LCP1 UTRN MECP2	1.95e-04	553	91	10	int:EZR
Interaction	MEN1 interactions	BPTF ARID1B WASHC2C MRPL12 ANLN ZC3H13 ZNF644 FNBP4 ZFR HEATR1 SMC2 DCTN1 ZMYM3 RAD21	2.03e-04	1029	91	14	int:MEN1
Interaction	RC3H2 interactions	KRT1 SMG7 MRPL12 KCTD5 PRRC2C KRT82 RBM19 HSPH1 OTUD4 ZFR PATL1	2.06e-04	667	91	11	int:RC3H2
Interaction	ATG16L1 interactions	MYOF SMG7 COPA ANLN CALU PRRC2C ZC3H13 TTLL4 FNBP4 PPP1R37 GPATCH8 PFKP SMC2 LCP1 ITPR1	2.06e-04	1161	91	15	int:ATG16L1
Interaction	IGF2BP2 interactions	GSPT2 SMG7 ANLN PRRC2C OTUD4 PATL1 DCTN1 MECP2	2.12e-04	357	91	8	int:IGF2BP2
Interaction	RAD18 interactions	BPTF CALU PRRC2C ZC3H13 SVIL ZFR UTRN ZMYM3 DNMT3A	2.22e-04	457	91	9	int:RAD18
Interaction	STIL interactions	ARID1B AKAP9 WASHC2C SMG7 ALMS1 HSPH1	2.23e-04	190	91	6	int:STIL
Interaction	HEXIM1 interactions	KRT1 ARID1B LATS1 COPA MRPL12 HSPH1 EIF3K MACF1 ZFR SMC2 LCP1 DCTN1 MECP2	2.25e-04	913	91	13	int:HEXIM1
Interaction	EED interactions	KRT1 BPTF COPA ANLN RBM19 ZC3H13 HSPH1 SVIL OBSCN EIF3K MACF1 ZFR HEATR1 SMC2 DCTN1 DNMT3A RAD21	2.27e-04	1445	91	17	int:EED
Interaction	RC3H1 interactions	KRT1 SMG7 MRPL12 KCTD5 PRRC2C RBM19 HSPH1 OTUD4 ZFR PATL1 SMC2	2.34e-04	677	91	11	int:RC3H1
Interaction	EFTUD2 interactions	KRT1 SLK COPA MRPL12 ANLN PRRC2C RBM19 HSPH1 FNBP4 EIF3K MACF1 PATL1 PFKP SMC2 DCTN1 MECP2 RAD21	2.35e-04	1449	91	17	int:EFTUD2
Interaction	KRT5 interactions	KRT1 LATS1 ANLN EVPL DCTN1 MECP2	2.42e-04	193	91	6	int:KRT5
Interaction	BAP1 interactions	KRT1 SLK COPA MRPL12 CALU PRRC2C ZC3H13 HSPH1 SVIL OTUD4 EIF3K MACF1 PFKP SMC2 LCP1 DCTN1	2.43e-04	1314	91	16	int:BAP1
Interaction	PAX6 interactions	BPTF TSHZ3 ARID1B ZNF644 MSANTD2 ZMYM3 RAD21 MAF	2.51e-04	366	91	8	int:PAX6
Interaction	H2AZ1 interactions	BPTF MRPL12 ANLN ZNF644 CHD1L SMC2 ZMYM3 DNMT3A	2.75e-04	371	91	8	int:H2AZ1
Interaction	RBM47 interactions	SMG7 PRRC2C RBM19 OTUD4 ZFR PATL1	3.26e-04	204	91	6	int:RBM47
Interaction	CBX1 interactions	ANLN ZNF644 CHD1L CDCA8 MECP2 ZMYM3 DNMT3A	3.29e-04	288	91	7	int:CBX1
Interaction	TJP2 interactions	LATS1 SMG7 ALMS1 ANLN SVIL DCTN1 ZMYM3	3.29e-04	288	91	7	int:TJP2
Interaction	MKRN2 interactions	SMG7 ALMS1 ANLN PRRC2C OTUD4 MACF1 PATL1 NCS1	3.52e-04	385	91	8	int:MKRN2
Interaction	SPRR3 interactions	UTP11 FNBP4 EVPL	3.65e-04	31	91	3	int:SPRR3
Interaction	THOC1 interactions	AKAP9 MRPL12 ANLN ZC3H13 UTRN MECP2	3.81e-04	210	91	6	int:THOC1
Interaction	H3C3 interactions	BPTF TSHZ3 ANLN ZNF644 CHD1L CDCA8 MECP2 ZMYM3 DNMT3A	3.98e-04	495	91	9	int:H3C3
Interaction	TDRD3 interactions	LATS1 SMG7 PRRC2C OTUD4 PATL1 DCTN1	4.00e-04	212	91	6	int:TDRD3
Interaction	HUWE1 interactions	BPTF AKAP9 COPA ANLN CALU HSPH1 ARHGEF12 EIF3K MACF1 UCK2 HEATR1 SMC2 DCTN1 MAF	4.38e-04	1110	91	14	int:HUWE1
Interaction	POLR1D interactions	POLR3D AKAP9 MRPL12 HEATR1 MECP2	4.48e-04	141	91	5	int:POLR1D
Interaction	BRCA1 interactions	BPTF SMG7 ALMS1 COPA ANLN POLE HSPH1 FNBP4 OBSCN ZFR PFKP DCTN1 ZMYM3 ITPR1 RAD21	4.50e-04	1249	91	15	int:BRCA1
Interaction	ATOH1 interactions	AKAP9 PRRC2C MACF1 UTRN	4.73e-04	80	91	4	int:ATOH1
Interaction	THOC2 interactions	AKAP9 MRPL12 ANLN UTRN MECP2 ZMYM3	4.75e-04	219	91	6	int:THOC2
Interaction	CLK3 interactions	GSPT2 ANLN ZC3H13 ZFR GPATCH8 MECP2	4.87e-04	220	91	6	int:CLK3
Interaction	FOXE1 interactions	POLE ZFR HEATR1 MECP2	4.96e-04	81	91	4	int:FOXE1
Interaction	LZTS2 interactions	CLIP4 LATS1 SMG7 ALMS1 ANLN ZNF644 TTLL4 PATL1 SMC2	5.08e-04	512	91	9	int:LZTS2
Interaction	FBXO38 interactions	TICRR TSHZ3 POLE ZNF644 GPATCH8	5.09e-04	145	91	5	int:FBXO38
Interaction	CALM1 interactions	VPS13D AKAP9 MYLK ANLN SVIL OBSCN ARHGEF12 UTRN FBXO30 ITPR1	5.21e-04	626	91	10	int:CALM1
Interaction	SNRPB interactions	LATS1 AKAP9 COPA ANLN FNBP4 MACF1 ZFR MECP2 NCS1	5.45e-04	517	91	9	int:SNRPB
Interaction	H3-3A interactions	BPTF TSHZ3 ANLN ZNF644 CHD1L GPATCH8 CDCA8 MECP2 ZMYM3 DNMT3A RAD21	5.49e-04	749	91	11	int:H3-3A
Interaction	SIM1 interactions	MECP2 DNMT3A	5.55e-04	8	91	2	int:SIM1
Interaction	PCED1B interactions	ZFR MECP2	5.55e-04	8	91	2	int:PCED1B
Interaction	R3HDM1 interactions	LATS1 SMG7 OTUD4 PATL1	5.70e-04	84	91	4	int:R3HDM1
Interaction	GAGE2E interactions	UTP11 ZC3H13 ZNF644	5.71e-04	36	91	3	int:GAGE2E
Interaction	SSX3 interactions	AKAP9 ARHGEF12 NCS1	5.71e-04	36	91	3	int:SSX3
Interaction	SMARCA5 interactions	BPTF ANLN CECR2 ZC3H13 SMC2 MECP2 RAD21 MAF	5.79e-04	415	91	8	int:SMARCA5
Interaction	HNRNPD interactions	EML5 MRPL12 ANLN OBSCN EIF3K EVPL ZFR GPATCH8 DCTN1 MECP2	6.04e-04	638	91	10	int:HNRNPD
Interaction	SMG7 interactions	TSHZ3 ARID1B LATS1 SMG7 OTUD4 PATL1 GPATCH8	6.06e-04	319	91	7	int:SMG7
Interaction	SMC1A interactions	BPTF COPA ANLN POLE OTUD4 SMC2 MECP2 RAD21	6.07e-04	418	91	8	int:SMC1A
Interaction	IMPDH2 interactions	SLK AKAP9 ALMS1 ANLN HSPH1 ARHGEF12 SMC2 MECP2	6.26e-04	420	91	8	int:IMPDH2
Interaction	TSR1 interactions	POLR3D MYLK SMG7 ANLN RBM19 DCTN1 MECP2	6.40e-04	322	91	7	int:TSR1
Interaction	KRT78 interactions	BPTF LATS1 ANLN MECP2	6.51e-04	87	91	4	int:KRT78
Interaction	MOV10 interactions	GSPT2 SMG7 COPA ANLN PRRC2C RBM19 FNBP4 OBSCN OTUD4 MACF1 ZFR PATL1 DCTN1 ZMYM3 FBXO30	6.66e-04	1297	91	15	int:MOV10
Interaction	PTP4A3 interactions	TSHZ3 SVIL ARHGEF12 HEATR1 SMC2	6.69e-04	154	91	5	int:PTP4A3
Interaction	CMYA5 interactions	CLIP4 ANLN CMYA5	6.70e-04	38	91	3	int:CMYA5
Interaction	KLF16 interactions	MRPL12 PRRC2C ZNF644 HSPH1 GPATCH8 PFKP ZMYM3 RAD21	6.76e-04	425	91	8	int:KLF16
Interaction	CEBPB interactions	BPTF TICRR TSHZ3 AKAP9 COPA MRPL12 CALU PRRC2C ZNF644 HSPH1 EIF3K ZFR GPATCH8 SMC2 LCP1 DCTN1	6.83e-04	1443	91	16	int:CEBPB
Interaction	NPHP4 interactions	KRT1 VPS13D LATS1 CALU KRT82 OBSCN	7.04e-04	236	91	6	int:NPHP4
Interaction	KIF23 interactions	LATS1 ALMS1 COPA ANLN CALU ZC3H13 PCLO SVIL OTUD4 MACF1 HEATR1 SMC2 CDCA8	7.16e-04	1031	91	13	int:KIF23
Interaction	DISC1 interactions	AKAP9 ALMS1 SVIL MACF1 SMC2 DCTN1 UTRN RAD21	7.19e-04	429	91	8	int:DISC1
Interaction	FXR2 interactions	LATS1 AKAP9 SMG7 ANLN PRRC2C CECR2 OTUD4 MECP2	7.30e-04	430	91	8	int:FXR2
Interaction	PLEC interactions	SLK LATS1 ANLN UTP11 MACF1 SMC2 MECP2 ITPR1	7.30e-04	430	91	8	int:PLEC
Interaction	CAPZA2 interactions	WASHC2C ANLN SVIL MACF1 SMC2 LCP1 DCTN1 ITPR1	7.30e-04	430	91	8	int:CAPZA2
Interaction	OBSL1 interactions	COPA CALU KRT82 RBM19 CECR2 PCLO OTUD4 MACF1 ZFR HEATR1 CDCA8 UTRN	7.31e-04	902	91	12	int:OBSL1
Cytoband	6q24	UTRN FBXO30	1.10e-04	8	92	2	6q24
GeneFamily	EF-hand domain containing	EFCAB5 CALU EFCAB13 DGKB MACF1 LCP1 NCS1	1.20e-05	219	64	7	863
GeneFamily	EF-hand domain containing\|Plakins	MACF1 EVPL	3.41e-04	8	64	2	939
GeneFamily	Fibronectin type III domain containing	FNDC1 MYLK OBSCN CMYA5	2.48e-03	160	64	4	555
Coexpression	GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP	BPTF TICRR PRRC2C POLE TTLL4 MACF1 SMC2 UTRN RAD21	1.34e-08	180	91	9	M8239
Coexpression	GSE32986_GMCSF_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_DN	EML5 ALMS1 RBM19 SVIL EFCAB13 FNBP4 DNMT3A	5.78e-06	197	91	7	M8611
Coexpression	JISON_SICKLE_CELL_DISEASE_DN	FAM153A PRRC2C FNBP4 OTUD4 EIF3K GPATCH8	4.76e-05	186	91	6	M4911
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	BPTF SLK LATS1 AKAP9 ZNF644 FNBP4 OTUD4 MACF1 ZFR GPATCH8 LCP1 UTRN MECP2 ITPR1 RAD21 MAF	5.07e-05	1492	91	16	M40023
Coexpression	GSE19941_UNSTIM_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_DN	TICRR UTP11 POLE SMC2 CDCA8 ITPR1	6.93e-05	199	91	6	M8109
Coexpression	GSE3982_MEMORY_CD4_TCELL_VS_TH2_DN	MYOF MRPL12 KCTD5 CALU SMC2 CDCA8	6.93e-05	199	91	6	M5382
Coexpression	GSE360_CTRL_VS_L_DONOVANI_MAC_DN	OTUD4 MACF1 UCK2 ZFR GPATCH8 UTRN	6.93e-05	199	91	6	M5159
Coexpression	GSE26343_WT_VS_NFAT5_KO_MACROPHAGE_UP	SLK MRPL12 ACOT11 UCK2 UTRN MAF	7.12e-05	200	91	6	M8644
Coexpression	GSE29618_PRE_VS_DAY7_FLU_VACCINE_PDC_DN	BPTF SMG7 COPA HSPH1 FNBP4 ZFR	7.12e-05	200	91	6	M4979
Coexpression	GSE24814_STAT5_KO_VS_WT_PRE_BCELL_DN	BPTF MYOF AKAP9 MRPL12 PRRC2C ITPR1	7.12e-05	200	91	6	M8427
CoexpressionAtlas	dev gonad_e13.5_M_GermCell_Oct_k-means-cluster#1_top-relative-expression-ranked_1000	GSPT2 ANLN POLE CECR2 HSPH1 OTUD4 CHD1L HEATR1 CDCA8 PHF13	1.48e-06	333	90	10	gudmap_dev gonad_e13.5_M_GermCell_Oct_k1_1000
CoexpressionAtlas	DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#2_top-relative-expression-ranked_1000	FMO1 COPA PRRC2C ZC3H13 SMC2 UTRN DNMT3A MAF	6.06e-06	230	90	8	gudmap_developingGonad_e16.5_ovary_1000_k2
CoexpressionAtlas	DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000	FNDC1 FMO1 GSPT2 MYLK COPA PRRC2C ZC3H13 FNBP4 SMC2 OGN UTRN DNMT3A MAF IFNAR1	6.30e-06	797	90	14	gudmap_developingGonad_P2_epididymis_1000
CoexpressionAtlas	gamma delta T cells, Tgd.vg2+24ahi.Th, TCRd+ Vg2+ CD24+, Thymus, avg-3	TICRR ANLN ANO6 POLE UCK2 SMC2 CDCA8 UTRN DNMT3A MAF	1.22e-05	423	90	10	GSM476655_500
CoexpressionAtlas	FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3	EML5 SMG7 ALMS1 ANLN PRRC2C POLE PCLO HSPH1 PATL1 SMC2 FBXO30	1.53e-05	532	90	11	Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3
CoexpressionAtlas	DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_1000	COPA PRRC2C ZC3H13 MSANTD2 SMC2 UTRN DNMT3A MAF	2.33e-05	277	90	8	gudmap_developingGonad_e12.5_ovary_k3_1000
CoexpressionAtlas	DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000	FNDC1 FMO1 MYLK COPA PRRC2C ZC3H13 FNBP4 SMC2 OGN UTRN DNMT3A MAF IFNAR1	3.11e-05	799	90	13	gudmap_developingGonad_e18.5_epididymis_1000
CoexpressionAtlas	dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_1000	GSPT2 EML5 ALMS1 ANLN POLE CECR2 HSPH1 OTUD4 CHD1L HEATR1 GPATCH8 CDCA8 PHF13	3.59e-05	810	90	13	gudmap_dev gonad_e13.5_M_GermCell_Oct_1000
CoexpressionAtlas	DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#4_top-relative-expression-ranked_500	AKAP9 OTUD4 SMC2 FBXO30 ITPR1	4.99e-05	94	90	5	gudmap_developingKidney_e15.5_Ureteral Smooth Musc_500_k4
CoexpressionAtlas	DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_500	FMO1 COPA PRRC2C ZC3H13 FNBP4 SMC2 UTRN MAF IFNAR1	5.42e-05	404	90	9	gudmap_developingGonad_e18.5_epididymis_500
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500	COPA PRRC2C ZC3H13 FNBP4 SMC2 UTRN DNMT3A MAF IFNAR1	6.42e-05	413	90	9	gudmap_developingGonad_e14.5_ epididymis_500
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_500	COPA PRRC2C ZC3H13 SMC2 UTRN MAF	6.59e-05	162	90	6	gudmap_developingGonad_e16.5_epididymis_500_k2
CoexpressionAtlas	DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#2_top-relative-expression-ranked_1000	COPA PRRC2C ZC3H13 MSANTD2 SMC2 UTRN DNMT3A MAF	6.90e-05	323	90	8	gudmap_developingGonad_e11.5_ovary + mesonephros_k2_1000
CoexpressionAtlas	B cells, proB.CLP.FL, CD19- IgM- CD43+ CD24intermediate CD45R- AA4.1+ CD, Fetal Liver, avg-1	TICRR ANLN POLE CECR2 UCK2 SMC2 CDCA8 NCS1 ADGRL4	7.04e-05	418	90	9	GSM538350_500
CoexpressionAtlas	gamma delta T cells, Tgd.vg2-24ahi.Th, TCRd+ Vg2- CD24+, Thymus, avg-2	TICRR ANLN POLE SMC2 CDCA8 UTRN ZMYM3 DNMT3A MAF	7.57e-05	422	90	9	GSM476658_500
CoexpressionAtlas	DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#3_top-relative-expression-ranked_1000	COPA PRRC2C ZC3H13 SMC2 UTRN DNMT3A MAF	9.15e-05	249	90	7	gudmap_developingGonad_P2_epididymis_1000_k3
CoexpressionAtlas	dev gonad_e11.5_M_PrimGermCell_Oct_k-means-cluster#2_top-relative-expression-ranked_1000	TICRR ANLN POLE CECR2 OTUD4 CHD1L CDCA8	1.14e-04	258	90	7	gudmap_dev gonad_e11.5_M_PrimGermCell_Oct_k2_1000
CoexpressionAtlas	FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000_k-means-cluster#1	AKAP9 EML5 ALMS1 ANLN PRRC2C POLE PCLO	1.17e-04	259	90	7	Facebase_RNAseq_e8.5_Floor Plate_1000_K1
CoexpressionAtlas	DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#3_top-relative-expression-ranked_1000	COPA PRRC2C ZC3H13 SMC2 UTRN DNMT3A MAF	1.17e-04	259	90	7	gudmap_developingGonad_e12.5_epididymis_k3_1000
CoexpressionAtlas	DevelopingKidney_e11.5_ureteric bud_emap-3844_k-means-cluster#2_top-relative-expression-ranked_500	TICRR FNBP4 UCK2 DNMT3A	1.23e-04	60	90	4	gudmap_developingKidney_e11.5_ureteric bud_500_k2
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000	VPS13D MYLK COPA PRRC2C ZC3H13 FNBP4 ZFR SMC2 UTRN DNMT3A MAF IFNAR1	1.24e-04	790	90	12	gudmap_developingGonad_e16.5_epididymis_1000
CoexpressionAtlas	DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000	CLIP4 FMO1 EML5 COPA PRRC2C ZC3H13 FNBP4 SMC2 UTRN DNMT3A MAF IFNAR1	1.31e-04	795	90	12	gudmap_developingGonad_e16.5_ovary_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5	LATS1 AKAP9 ALMS1 MACF1 SMC2 RAD21	1.41e-04	186	90	6	Facebase_RNAseq_e10.5_Mandibular Arch_500_K5
CoexpressionAtlas	DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000	COPA PRRC2C ZC3H13 HSPH1 FNBP4 MSANTD2 SMC2 UTRN FBXO30 DNMT3A MAF IFNAR1	1.65e-04	815	90	12	gudmap_developingGonad_e11.5_ovary + mesonephros_1000
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_1000	COPA ZC3H13 MSANTD2 SMC2 UTRN DNMT3A MAF	1.69e-04	275	90	7	gudmap_developingGonad_e14.5_ epididymis_1000_k3
CoexpressionAtlas	facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4	EFCAB5 BPTF TICRR FMO1 GSPT2 AKAP9 EML5 ALMS1 KCNH2 ATP8A2 ZC3H13 TTLL4 HSPH1 ZFR GPATCH8 SMC2	1.89e-04	1370	90	16	facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4
CoexpressionAtlas	DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_1000	COPA PRRC2C ZC3H13 SMC2 UTRN DNMT3A MAF	1.93e-04	281	90	7	gudmap_developingGonad_e18.5_epididymis_1000_k3
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_1000	COPA PRRC2C ZC3H13 SMC2 UTRN DNMT3A MAF	2.06e-04	284	90	7	gudmap_developingGonad_e16.5_epididymis_1000_k2
CoexpressionAtlas	DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_500	AKAP9 PRRC2C ZNF644 OTUD4 PFKP SMC2	2.15e-04	201	90	6	gudmap_developingKidney_e15.5_500_k3
CoexpressionAtlas	DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#5_top-relative-expression-ranked_1000	AKAP9 PRRC2C OTUD4 SMC2 FBXO30 ITPR1	2.27e-04	203	90	6	gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000_k5
CoexpressionAtlas	FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#4	SLK HSPH1 ARHGEF12 MACF1 LCP1 UTRN	2.27e-04	203	90	6	Facebase_RNAseq_e9.5_Mandibular Arch_1000_K4
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500	MYOF FNDC1 LATS1 AKAP9 ALMS1 CECR2 MACF1 SMC2 RAD21	2.40e-04	492	90	9	Facebase_RNAseq_e10.5_Mandibular Arch_500
CoexpressionAtlas	B cells, proB.FrA.BM, CD19- IgM- CD43+ CD24intermediate CD45R+ AA4.1+ CD, Bone marrow, avg-2	TICRR ANLN POLE CECR2 SMC2 CDCA8 ADGRL4 ITPR1	2.43e-04	388	90	8	GSM538352_500
CoexpressionAtlas	alpha beta T cells, NKT.44+NK1.1-.Th, aGC CD1d tet CD3 CD44, Thymus, avg-3	TICRR ANLN ATP8A2 POLE SMC2 CDCA8 UTRN MAF	2.60e-04	392	90	8	GSM538335_500
CoexpressionAtlas	DevelopingKidney_e11.5_metaneph mesench_emap-3843_k-means-cluster#5_top-relative-expression-ranked_500	SMG7 POLE FNBP4 UCK2 DNMT3A	2.66e-04	134	90	5	gudmap_developingKidney_e11.5_metaneph mesench_500_k5
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_MedNas_2500	TICRR AKAP9 EML5 ALMS1 KCNH2 ATP8A2 CECR2 ZC3H13 ZNF644 TTLL4 HSPH1 MACF1 HEATR1 SMC2 TGM5 ADGRL4	2.71e-04	1414	90	16	facebase_RNAseq_e10.5_Emin_MedNas_2500
CoexpressionAtlas	DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#2_top-relative-expression-ranked_1000	COPA PRRC2C ZC3H13 SMC2 UTRN MAF	2.72e-04	210	90	6	gudmap_developingGonad_e18.5_ovary_1000_k2
CoexpressionAtlas	DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_500	FNDC1 FMO1 COPA PRRC2C ZC3H13 FNBP4 SMC2 OGN	2.74e-04	395	90	8	gudmap_developingGonad_P2_epididymis_500
CoexpressionAtlas	alpha beta T cells, NKT.44-NK1.1-.Th, aGC CD1d tet CD3e, Thymus, avg-2	TICRR ANLN POLE HSPH1 SMC2 CDCA8 UTRN MAF	2.88e-04	398	90	8	GSM538338_500
CoexpressionAtlas	alpha beta T cells, T.DPbl.Th, 4+ 8+ TCR-/lo FSChi, Thymus, avg-3	TICRR ALMS1 ANLN ANO6 POLE SMC2 CDCA8 RAD21	2.88e-04	398	90	8	GSM399397_500
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500	COPA PRRC2C ZC3H13 FNBP4 SMC2 UTRN MAF IFNAR1	3.29e-04	406	90	8	gudmap_developingGonad_e16.5_epididymis_500
CoexpressionAtlas	gamma delta T cells, Tgd.vg2+24ahi.Th.TCRbko, TCRd+ Vg2+ CD24+, Thymus, avg-3	TICRR ANLN ANO6 POLE UCK2 SMC2 CDCA8 MAF	3.63e-04	412	90	8	GSM605793_500
CoexpressionAtlas	alpha beta T cells, T.ISP.Th, 4- 8+ TCR-/lo 24hi, Thymus, avg-3	TICRR ALMS1 ANLN ANO6 POLE UCK2 SMC2 CDCA8	3.94e-04	417	90	8	GSM399403_500
CoexpressionAtlas	B cells, proB.CLP.FL, CD19- IgM- CD43+ CD24intermediate AA4.1+ CD45R- CD, Fetal Liver, avg-2	TICRR ANLN POLE CECR2 UCK2 SMC2 CDCA8 ADGRL4	4.06e-04	419	90	8	GSM538348_500
CoexpressionAtlas	DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#5_top-relative-expression-ranked_500	COPA PRRC2C ZC3H13 SMC2 UTRN	4.46e-04	150	90	5	gudmap_developingGonad_e12.5_epididymis_k5_500
CoexpressionAtlas	DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#5_top-relative-expression-ranked_1000	FMO1 COPA PRRC2C ZC3H13 SMC2	4.60e-04	151	90	5	gudmap_developingGonad_P2_ovary_1000_k5
CoexpressionAtlas	facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500	KRT1 POLR3D GSPT2 AKAP9 EML5 MYLK ALMS1 RBM19 CECR2 ZC3H13 HSPH1 CHD1L HEATR1 PFKP SMC2	5.09e-04	1347	90	15	facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500
CoexpressionAtlas	B cells, proB.CLP.FL, CD19- IgM- CD43+ CD24intermediate CD45R- AA4.1+ CD, Fetal Liver, avg-1	ANLN CECR2 CDCA8 ADGRL4	5.14e-04	87	90	4	GSM538350_100
CoexpressionAtlas	dev gonad_e12.5_M_GermCellTestis_Oct_top-relative-expression-ranked_1000	TICRR ALMS1 ANLN POLE CECR2 OTUD4 CHD1L HEATR1 PFKP CDCA8 PHF13	5.32e-04	795	90	11	gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_1000
CoexpressionAtlas	DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000	COPA PRRC2C ZC3H13 MSANTD2 SMC2 UTRN FBXO30 DNMT3A RAD21 MAF IFNAR1	5.84e-04	804	90	11	gudmap_developingGonad_e12.5_ovary_1000
CoexpressionAtlas	DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_500	COPA ZC3H13 SMC2 UTRN MAF	6.16e-04	161	90	5	gudmap_developingGonad_e12.5_ovary_k3_500
CoexpressionAtlas	FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2	BPTF SLK WASHC2C ZC3H13 HSPH1 MACF1 HEATR1 CDCA8 UTRN	6.46e-04	564	90	9	Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2
CoexpressionAtlas	dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000	TICRR EML5 ALMS1 ANLN POLE CECR2 OTUD4 CHD1L HEATR1 GPATCH8 CDCA8	6.87e-04	820	90	11	gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3	BPTF TICRR AKAP9 EML5 ALMS1 ANLN POLE ZC3H13 ZNF644 HSPH1 MACF1 HEATR1 SMC2 TGM5	7.98e-04	1257	90	14	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3
CoexpressionAtlas	FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1	AKAP9 ALMS1 ANLN PRRC2C POLE HSPH1 SMC2 FBXO30	8.50e-04	469	90	8	Facebase_RNAseq_e8.5_Floor Plate_2500_K1
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#2	AKAP9 PCLO HSPH1 ARHGEF12 RAD21	8.52e-04	173	90	5	Facebase_RNAseq_e10.5_Maxillary Arch_1000_K2
CoexpressionAtlas	DevelopingKidney_e11.5_ureteric bud_emap-3844_k-means-cluster#1_top-relative-expression-ranked_1000	TICRR GSPT2 SMG7 FNBP4 UCK2 DNMT3A	8.56e-04	261	90	6	gudmap_developingKidney_e11.5_ureteric bud_1000_k1
CoexpressionAtlas	dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#2_top-relative-expression-ranked_1000	ANLN POLE OTUD4 CHD1L HEATR1 GPATCH8 CDCA8	8.64e-04	361	90	7	gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k2_1000
CoexpressionAtlas	FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_1000	SLK CECR2 HSPH1 ARHGEF12 OTUD4 MACF1 UCK2 HEATR1 GPATCH8 LCP1 UTRN NCS1	8.90e-04	983	90	12	Facebase_RNAseq_e9.5_Mandibular Arch_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000	TICRR LATS1 AKAP9 KCNH2 CECR2 PCLO ARHGEF12 MACF1 SMC2 LCP1 UTRN MECP2	9.05e-04	985	90	12	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000	TICRR SLK AKAP9 ACOT11 CECR2 PCLO HSPH1 ARHGEF12 MACF1 SMC2 LCP1 RAD21	9.38e-04	989	90	12	Facebase_RNAseq_e10.5_Maxillary Arch_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4	BPTF SLK EML5 PCLO ARHGEF12 MACF1 GPATCH8 LCP1 RAD21	9.42e-04	595	90	9	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4
CoexpressionAtlas	dev gonad_e12.5_M_GermCellTestis_Oct_k-means-cluster#2_top-relative-expression-ranked_1000	ANLN POLE CECR2 OTUD4 CHD1L CDCA8	9.44e-04	266	90	6	gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_k2_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_adult_bladder_emap-29457_k-means-cluster#4_top-relative-expression-ranked_1000	FNDC1 MYLK PFKP OGN	1.00e-03	104	90	4	gudmap_developingLowerUrinaryTract_adult_bladder_1000_k4
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#3	LATS1 AKAP9 ALMS1 MACF1 FBXO30 RAD21	1.04e-03	271	90	6	Facebase_RNAseq_e10.5_Mandibular Arch_1000_K3
CoexpressionAtlas	B cells, proB.FrBC.BM, CD19+ IgM- CD45R+ CD43+ HSA+, Bone marrow, avg-1	TICRR ANLN POLE CECR2 SMC2 CDCA8 ADGRL4	1.09e-03	376	90	7	GSM538418_500
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#2_top-relative-expression-ranked_500	COPA ZC3H13 SMC2 MAF	1.12e-03	107	90	4	gudmap_developingGonad_e14.5_ epididymis_500_k2
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500	AKAP9 CECR2 PCLO ARHGEF12 MACF1 SMC2 LCP1 UTRN	1.16e-03	492	90	8	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500	BPTF TICRR AKAP9 EML5 ALMS1 ANLN POLE CECR2 ZC3H13 ZNF644 HSPH1 MACF1 HEATR1 SMC2 TGM5	1.16e-03	1459	90	15	facebase_RNAseq_e10.5_Emin_LatNas_2500
CoexpressionAtlas	facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K1	KRT1 POLR3D GSPT2 AKAP9 EML5 ALMS1 RBM19 ZC3H13 HSPH1 CHD1L HEATR1 PFKP SMC2	1.22e-03	1164	90	13	facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K1
CoexpressionAtlas	dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_500	TICRR EML5 ALMS1 ANLN POLE CECR2 CHD1L	1.25e-03	385	90	7	gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_500
CoexpressionAtlas	kidney_P3_CapMes_Crym_top-relative-expression-ranked_1000	TICRR MYLK ALMS1 POLE CECR2 PCLO ARHGEF12 UCK2 CDCA8 NCS1	1.26e-03	749	90	10	gudmap_kidney_P3_CapMes_Crym_1000
CoexpressionAtlas	facebase_RNAseq_e8.5_ParaxMesoderm_2500_K2	POLR3D FMO1 MRPL12 RBM19 CECR2 TTLL4 HSPH1 OTUD4 EIF3K UCK2 HEATR1 PFKP SMC2	1.32e-03	1175	90	13	facebase_RNAseq_e8.5_ParaxMesoderm_2500_K2
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#4	AKAP9 PCLO ARHGEF12 MACF1 SMC2	1.35e-03	192	90	5	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500_K4
CoexpressionAtlas	DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_top-relative-expression-ranked_500	TSHZ3 AKAP9 MYLK OTUD4 SMC2 FBXO30 ITPR1	1.41e-03	393	90	7	gudmap_developingKidney_e15.5_Ureteral Smooth Musc_500
CoexpressionAtlas	dev gonad_e12.5_F_GermCellOvary_Oct_k-means-cluster#3_top-relative-expression-ranked_500	TICRR ANLN POLE OTUD4	1.41e-03	114	90	4	gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_k3_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#5_top-relative-expression-ranked_1000	LATS1 COPA OTUD4 HEATR1 SMC2 UTRN DNMT3A	1.49e-03	397	90	7	gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000_k5
CoexpressionAtlas	alpha beta T cells, preT.DN3-4.Th, Lin-/lo CD25int CD44- CD28+, Thymus, avg-3	TICRR ALMS1 ANLN POLE UCK2 SMC2 CDCA8	1.49e-03	397	90	7	GSM791143_500
CoexpressionAtlas	B cells, proB.CLP.BM, CD19- IgM- CD43+ CD24intermediate CD45R- AA4.1+ CD, Bone marrow, avg-2	TICRR MYOF ANLN POLE SMC2 CDCA8 ADGRL4	1.54e-03	399	90	7	GSM538345_500
CoexpressionAtlas	B cells, proB.FrBC.BM, CD19+ IgM- CD43+ AA4.1+ CD45R+, Bone marrow, avg-2	TICRR ANLN POLE CECR2 SMC2 CDCA8 ADGRL4	1.58e-03	401	90	7	GSM399450_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#4	GSPT2 AKAP9 EML5 ALMS1 RBM19 PCLO	1.69e-03	298	90	6	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K4
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_MedNas_2500_K1	TICRR AKAP9 EML5 ALMS1 KCNH2 ZC3H13 ZNF644 TTLL4 HSPH1 MACF1 HEATR1 SMC2	1.69e-03	1060	90	12	facebase_RNAseq_e10.5_Emin_MedNas_2500_K1
CoexpressionAtlas	dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_500	TICRR ALMS1 ANLN POLE CECR2 OTUD4 HEATR1	1.70e-03	406	90	7	gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1	TICRR LATS1 AKAP9 CECR2 ZNF644 ARHGEF12 MACF1 SMC2 MECP2 IFNAR1	1.71e-03	780	90	10	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1
CoexpressionAtlas	B cells, preB.FrC.BM, CD19+ IgM- CD45R+ CD43+ HSA+, Bone marrow, avg-3	TICRR ALMS1 ANLN POLE CECR2 SMC2 CDCA8	1.77e-03	409	90	7	GSM399452_500
CoexpressionAtlas	DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_500	COPA ZC3H13 SMC2 UTRN FBXO30 MAF IFNAR1	1.77e-03	409	90	7	gudmap_developingGonad_e12.5_ovary_500
CoexpressionAtlas	Fetal Liver, SC.STSL.FL, IgM- CD24- CD117+ IL7R- CD150- CD48- AA4.1+ CD43+, Fetal Liver, avg-2	TICRR ANLN POLE CECR2 SMC2 CDCA8 ADGRL4	1.80e-03	410	90	7	GSM791122_500
CoexpressionAtlas	facebase_RNAseq_e8.5_FloorPlate_2500_K3	TICRR POLR3D GSPT2 AKAP9 EML5 ALMS1 HSPH1 OTUD4 UCK2 HEATR1 GPATCH8 PFKP SMC2 MAF	1.83e-03	1371	90	14	facebase_RNAseq_e8.5_FloorPlate_2500_K3
CoexpressionAtlas	B cells, proB.FrA.BM, AA4.1+ CD117+ IL7R+ CD45R+ CD24- CD19- IgM-, Bone marrow, avg-1	ANLN POLE CECR2 SMC2 CDCA8 ADGRL4	1.86e-03	304	90	6	GSM538354_500
CoexpressionAtlas	gamma delta T cells, Tgd.vg2+24ahi.e17.Th, TCRd+ Vg2+ CD24+, Fetal Thymus, avg-3	TICRR ANLN POLE UCK2 SMC2 CDCA8 MAF	1.90e-03	414	90	7	GSM476660_500
CoexpressionAtlas	alpha beta T cells, preT.DN2-3.Th, Lin-/lo CD25hi CD44Int, Thymus, avg-2	TICRR FNDC1 ANLN POLE UCK2 CDCA8 NCS1	1.92e-03	415	90	7	GSM791134_500
CoexpressionAtlas	DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_1000	BPTF AKAP9 PRRC2C CECR2 ZNF644 FNBP4 OTUD4 PFKP SMC2 UTRN	1.96e-03	795	90	10	gudmap_developingKidney_e15.5_anlage of loop of Henle_1000
CoexpressionAtlas	alpha beta T cells, preT.DN2B.Th, Lin-/lo CD25hi CD44+ cKitint, Thymus, avg-2	TICRR ANLN POLE UCK2 SMC2 CDCA8 NCS1	2.06e-03	420	90	7	GSM791141_500
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000	COPA PRRC2C ZC3H13 FNBP4 MSANTD2 SMC2 UTRN DNMT3A MAF IFNAR1	2.07e-03	801	90	10	gudmap_developingGonad_e14.5_ epididymis_1000
CoexpressionAtlas	Stem Cells, SC.LTSL.BM, IgM- CD24- CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Bone marrow, avg-2	TICRR MYOF ARID1B ANLN POLE ARHGEF12 ADGRL4	2.11e-03	422	90	7	GSM399442_500
CoexpressionAtlas	B cells, MLP.BM, CD19- IgM- CD43+ CD24- AA4.1+ CD45R- CD117+ IL7R-, Bone marrow, avg-2	TICRR ANLN POLE UCK2 CDCA8 NCS1 ADGRL4	2.11e-03	422	90	7	GSM791124_500
CoexpressionAtlas	B cells, proB.FrA.FL, CD19- IgM- CD43+ CD24intermediate CD45R+ AA4.1+ CD, Fetal Liver, avg-1	TICRR ANLN POLE CECR2 SMC2 CDCA8 ADGRL4	2.11e-03	422	90	7	GSM538357_500
CoexpressionAtlas	B cells, proB.FrA.FL, CD19- IgM- CD43+ CD24intermediate AA4.1+ CD45R+ CD, Fetal Liver, avg-2	TICRR ANLN POLE CECR2 SMC2 CDCA8 ADGRL4	2.11e-03	422	90	7	GSM538355_500
CoexpressionAtlas	Fetal Liver, SC.LTSL.FL, IgM- CD24- CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Fetal Liver, avg-3	TICRR ALMS1 ANLN POLE SMC2 CDCA8 ADGRL4	2.14e-03	423	90	7	GSM791126_500
CoexpressionAtlas	facebase_RNAseq_e10.5_MandArch_2500_K1	TICRR POLR3D AKAP9 ALMS1 POLE CECR2 ZNF644 HSPH1 MACF1 HEATR1 SMC2 TGM5 DNMT3A	2.15e-03	1241	90	13	facebase_RNAseq_e10.5_MandArch_2500_K1
ToppCell	(10)_Ciliated-(2)_GFP_FOXI1\|(10)_Ciliated / shred by cell type by condition	BPTF VPS13D AKAP9 PRRC2C ZC3H13 ZNF644 HSPH1 ZFR SAMD15 CCDC39	1.20e-11	199	92	10	61b1ed2db71b96157b92b7535d1955a4033098da
ToppCell	PND10\|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	BPTF AKAP9 MYLK CALU ARHGEF12 MACF1 UTRN	1.39e-07	190	92	7	d67e2814047c8df2ae4b7bc8be9539f5df6ecef2
ToppCell	human_hepatoblastoma\|World / Sample and Cell Type and Tumor Cluster (all cells)	BPTF ARID1B AKAP9 PRRC2C HSPH1 UTRN RAD21	1.54e-07	193	92	7	e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-3m\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SMG7 COPA CALU PRRC2C ARHGEF12 UTRN FBXO30	1.71e-07	196	92	7	151f1a29a91f8b234e9b6ed062666357a2f69128
ToppCell	mild-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	BPTF ARID1B AKAP9 PRRC2C ZNF644 MACF1 UTRN	1.90e-07	199	92	7	f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell	(03)_KRT6B+-(2)_GFP_FOXI1\|(03)_KRT6B+ / shred by cell type by condition	BPTF AKAP9 PRRC2C ZC3H13 ZNF644 PCLO UTRN	1.90e-07	199	92	7	c425e7975f492ed5cfcca022248adb627e1d27d4
ToppCell	(01)_IL1RL1+-(2)_GFP_FOXI1\|(01)_IL1RL1+ / shred by cell type by condition	BPTF AKAP9 PRRC2C ZC3H13 ZNF644 HSPH1 ZFR	1.90e-07	199	92	7	a2f7d0cabf35b80fe239fae34a77bf9344d5d743
ToppCell	control\|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	MYOF SLK AKAP9 ACOT11 PCLO ARHGEF12 EVPL	1.96e-07	200	92	7	97f36d2c197e03d93a1fc59949d77ae90f6e6a9a
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	BPTF ARID1B AKAP9 PRRC2C ZNF644 MACF1 UTRN	1.96e-07	200	92	7	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Intermediate\|6m / Sample Type, Dataset, Time_group, and Cell type.	BPTF AKAP9 PRRC2C ZC3H13 FNBP4 SMC2 OGN	1.96e-07	200	92	7	7c261e39ac30b318511373ab7302aa53b8b81b9c
ToppCell	COVID-19\|World / Disease, condition lineage and cell class	BPTF ARID1B PRRC2C MACF1 LCP1 UTRN RAD21	1.96e-07	200	92	7	7dec470c379cd89f05a0f37c8628b21f136e52f0
ToppCell	NS-control\|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	MYOF SLK AKAP9 ACOT11 PCLO ARHGEF12 EVPL	1.96e-07	200	92	7	ecbe89ff95d046155b984c8c150e0b9e7278f839
ToppCell	3'_v3-blood-Lymphocytic_T_CD4-T_CD4/CD8\|blood / Manually curated celltypes from each tissue	FNDC1 AKAP9 PRRC2C MACF1 CFAP57 UTRN	3.77e-07	135	92	6	ae2d3a42e567b5bade304c0caa497eb725be3565
ToppCell	PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_G2M\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TICRR ANLN PPP1R37 FAM227A CDCA8 PHF13	1.66e-06	174	92	6	1779e67382cb2644534ffb5b9b8f28d32935f4ea
ToppCell	droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating-classical_monocyte_proliferating_l33-52\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	EFCAB5 ANLN POLE UCK2 SMC2 CDCA8	2.37e-06	185	92	6	47c69500877b851c0c9744f5e1ef2ee0bff99168
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KRT1 SLK COPA CALU UTRN FBXO30	2.37e-06	185	92	6	eb7d3c1363d5fedc611f9c1a91ea823de251355e
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1\|TCGA-Pancreas / Sample_Type by Project: Shred V9	VPS13D MYLK ALMS1 ZC3H13 ZNF644 ARHGEF12	2.44e-06	186	92	6	03db813598b67b1e08f759758a1c2023396921fa
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	ARID1B ZNF644 HSPH1 MACF1 UTRN ITPR1	2.60e-06	188	92	6	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FNDC1 MYLK CALU ZC3H13 OGN ADGRL4	2.85e-06	191	92	6	89d03c4133dda852a3713c0902a7d67941cf5b21
ToppCell	human_hepatoblastoma-Tumor_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	BPTF ARID1B AKAP9 HSPH1 UTRN RAD21	2.94e-06	192	92	6	916fbec1c7ab7969bda711886ac88e877e30c280
ToppCell	5'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MYOF MYLK SVIL DGKB MACF1 OGN	3.03e-06	193	92	6	0256e8fe4a47f2e2a43ef9d19bfc047d20806d69
ToppCell	COPD-Endothelial-VE_Peribronchial\|Endothelial / Disease state, Lineage and Cell class	MYOF SVIL OTUD4 UCK2 HEATR1 ADGRL4	3.12e-06	194	92	6	8dcde77767b23e75360adb316cdccf56a00e3726
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AKAP9 PRRC2C PCLO MACF1 ZFR DNMT3A	3.21e-06	195	92	6	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AKAP9 PRRC2C PCLO MACF1 ZFR DNMT3A	3.21e-06	195	92	6	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	LPS_IL1RA_TNF\|World / Treatment groups by lineage, cell group, cell type	MYOF AKAP9 MYLK OGN UTRN CCDC39	3.40e-06	197	92	6	0a6550dce156fc81f15b1e7830d331ca50d87d06
ToppCell	5'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FNDC1 MYLK KCNH2 CALU SVIL OGN	3.40e-06	197	92	6	94a7270ea6d4b586f58875c9e4071ce0f683ef7e
ToppCell	(11)_FOXN4+-(2)_GFP_FOXI1\|(11)_FOXN4+ / shred by cell type by condition	BPTF VPS13D AKAP9 ZC3H13 ZNF644 UTRN	3.51e-06	198	92	6	76d40b8c2f8399725b3a62ee2ae0896559cf91eb
ToppCell	(00)_Basal-(2)_GFP_FOXI1\|(00)_Basal / shred by cell type by condition	BPTF AKAP9 PRRC2C ZC3H13 HSPH1 ZFR	3.61e-06	199	92	6	19674e1eaeb51e4196d847cb62aa437c852951d3
ToppCell	(02)_MMP9/10+-(2)_GFP_FOXI1\|(02)_MMP9/10+ / shred by cell type by condition	BPTF AKAP9 MYLK ZC3H13 ARHGEF12 RAD21	3.61e-06	199	92	6	18a7f9ced4364f45b184bd529f32ef02c27779d3
ToppCell	(04)_Interm._basal>secr.-(2)_GFP_FOXI1\|(04)_Interm._basal>secr. / shred by cell type by condition	BPTF AKAP9 PRRC2C ZC3H13 HSPH1 ZFR	3.61e-06	199	92	6	53ca3861f9e00dab3f3fbefb0837857ee39ab084
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-FOXM1\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	TICRR ANLN POLE SMC2 CDCA8 RAD21	3.61e-06	199	92	6	98575fcce726589e93fbb4df1aab03e57cb56076
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial-FOXM1\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	TICRR ANLN POLE SMC2 CDCA8 RAD21	3.71e-06	200	92	6	4cfe08878a6981bf7b3567f9e82192d8f060ddde
ToppCell	Control_saline-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|Control_saline / Treatment groups by lineage, cell group, cell type	MYOF TSHZ3 FNDC1 MYLK KCNH2 SVIL	3.71e-06	200	92	6	c5e051f1aac8dda376c342a9932785a23450e073
ToppCell	Control_saline-Endothelial-Endothelial-FOXM1\|Control_saline / Treatment groups by lineage, cell group, cell type	TICRR ANLN POLE SMC2 CDCA8 RAD21	3.71e-06	200	92	6	9bbc7b5561151f6ff65f40b3226271def732e5d9
ToppCell	Control_saline-Mesenchymal_myocytic-Myofibroblastic\|Control_saline / Treatment groups by lineage, cell group, cell type	MYOF TSHZ3 FNDC1 MYLK KCNH2 SVIL	3.71e-06	200	92	6	9d5b3c2dcfa55d50acc2ce2c319d51aa525d4cd1
ToppCell	(08)_Brush+PNEC-(2)_GFP_FOXI1\|(08)_Brush+PNEC / shred by cell type by condition	BPTF AKAP9 PRRC2C ZC3H13 ZFR	1.00e-05	138	92	5	817e3f639604ea95adae01e8685ffaa2e0aff7a8
ToppCell	droplet-Lung-21m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l15\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	VPS13D SLK ZNF644 OTUD4 MAF	2.37e-05	165	92	5	94a5211072464fc24592bb107a853ce832e816fe
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_S-high\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TICRR ANLN POLE CDCA8 OGN	2.66e-05	169	92	5	e7514956b2e4298222ec443f98b2f5289451786e
ToppCell	Frontal_cortex-Neuronal-Inhibitory\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	KRT1 FNDC1 KCNH2 PRRC2C MAF	2.66e-05	169	92	5	78eb70dd916724e476eabccf18fb7fcec4210308
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	AKAP9 PRRC2C HSPH1 MACF1 UTRN	2.82e-05	171	92	5	2e9a20f8980b78325c52065a9c14ab3656267c05
ToppCell	PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYOF ANLN SMC2 CDCA8 RAD21	2.90e-05	172	92	5	29c8510f26527d487d0fc3543102d067cdb281a6
ToppCell	droplet-Lung-1m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-proliferating_NK\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CLIP4 TICRR KCNH2 SMC2 CDCA8	2.98e-05	173	92	5	c399786aa25bdbe3394988db6955842b5b7e6b41
ToppCell	Healthy_Control-Myeloid-Mast\|Healthy_Control / Condition, Lineage, Cell class and cell subclass	KRT1 ACOT11 KCNH2 OBSCN EVPL	3.14e-05	175	92	5	ca187074adcc9b8bd0fa270e2ede1564c8e6c6cf
ToppCell	Healthy_Control-Myeloid-Mast-\|Healthy_Control / Condition, Lineage, Cell class and cell subclass	KRT1 ACOT11 KCNH2 OBSCN EVPL	3.14e-05	175	92	5	eadbbcdf2aef4cee268bc70a7a2c4175d898953b
ToppCell	P03-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	FMO1 MYLK MACF1 OGN MAF	3.14e-05	175	92	5	282f09bbdfa70d93b3f66591dcfb84c5ee0268c7
ToppCell	Influenza_Severe-Plasmablast\|World / Disease group and Cell class	TICRR EML5 ANLN CDCA8 CCDC39	3.14e-05	175	92	5	14df8fc6f6beae1be7b7bd5837546d1ac1239a6f
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_G2M\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TICRR ELOA2 ANLN SMC2 CDCA8	3.14e-05	175	92	5	876cea684faf42ff3eb4623ad6d7a1fb1276ee02
ToppCell	cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	FNDC1 MYLK KCNH2 SVIL OGN	3.41e-05	178	92	5	8ec2a25dda96c9cc9c2904b6cb18f75a293f4969
ToppCell	cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_2\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	FNDC1 MYLK KCNH2 SVIL OGN	3.41e-05	178	92	5	6c91331196696e0cf239d105f458e3230659fa38
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c03-MKI67\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	TICRR ANLN SMC2 CDCA8 NCS1	3.41e-05	178	92	5	dbde3305e0c6a81593fe614e3f2e746b32cc16a7
ToppCell	PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ANLN TTLL4 SMC2 CDCA8 RAD21	3.60e-05	180	92	5	5e1680088065be14447d5d5465f91f7edd071a1e
ToppCell	droplet-Lung-LUNG-30m-Lymphocytic-Proliferating_NK\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TICRR POLE EVPL SMC2 CDCA8	3.79e-05	182	92	5	0370b395ceb9d4d66f80cf60dd8c28ac60af5c7b
ToppCell	droplet-Marrow-nan-3m-Myeloid-Cd4_positive_Macrophages\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GSPT2 HSPH1 UCK2 HEATR1 ADGRL4	3.89e-05	183	92	5	92ef926e6c1de8477fa4f35d1dae85482d8009de
ToppCell	TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-5\|TCGA-Liver / Sample_Type by Project: Shred V9	TICRR ANLN UTP11 SMC2 CDCA8	3.89e-05	183	92	5	f604a8b62c7088fad8365dbf8d910fc980bd3ba8
ToppCell	droplet-Marrow-nan-3m-Myeloid-macrophage\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GSPT2 HSPH1 UCK2 HEATR1 ADGRL4	3.89e-05	183	92	5	24db9cc717e651586317c6a8e03a3401651273c1
ToppCell	droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	EFCAB5 POLE UCK2 SMC2 CDCA8	3.89e-05	183	92	5	6c1d7ce60e67bf1df364a4e177c351e7313eb41f
ToppCell	Control-Endothelial-VE_Peribronchial\|Endothelial / Disease state, Lineage and Cell class	MYOF ANO6 OTUD4 UCK2 ADGRL4	4.31e-05	187	92	5	5429ae85942b8ec3895cceb63c663de3c24ca064
ToppCell	(04)_Pre-ciliated-(3)_72hpi\|(04)_Pre-ciliated / shred by cell type and Timepoint	C20orf96 VPS13D HSPH1 CFAP57 CCDC39	4.42e-05	188	92	5	f911dc61b008b60aaa2a1e9354085f480a669e2c
ToppCell	LA-13._Vascular_Smooth_Muscle\|LA / Chamber and Cluster_Paper	MYOF MYLK SVIL MACF1 ITPR1	4.42e-05	188	92	5	34e1b074a3995aa46ab194eb45115d76d1a5514d
ToppCell	E16.5-samps-Mesenchymal\|E16.5-samps / Age Group, Lineage, Cell class and subclass	TSHZ3 MYLK MACF1 OGN MAF	4.42e-05	188	92	5	3f0f662be684e3a4c6652e636cc135a39a1d2790
ToppCell	PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FNDC1 ANLN SMC2 CDCA8 RAD21	4.42e-05	188	92	5	95d0a796d62ce6d121e2028c378faffc14b35275
ToppCell	Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	FNDC1 MYLK KCNH2 CALU NCS1	4.42e-05	188	92	5	c29aaae3c5bb7cd6b9b3defd4d27afde3af19ba0
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	CLIP4 FNDC1 MYLK KCNH2 SVIL	4.42e-05	188	92	5	f54b063025d80de631382bf5326bc40aab7f7d00
ToppCell	COPD-Epithelial-Mesothelial\|Epithelial / Disease state, Lineage and Cell class	FAM153A ANO6 UCK2 OGN MAF	4.42e-05	188	92	5	159d63ecc3653a7449fc6acefd6ef0464845260e
ToppCell	Control-Endothelial-Endothelial-FOXM1\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TICRR ANLN POLE SMC2 CDCA8	4.54e-05	189	92	5	1e1499b062d9c647c8f38b0c4e0d871d159be5dd
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	CLIP4 FNDC1 MYLK KCNH2 SVIL	4.65e-05	190	92	5	938d1f66094b1c94606e0d40213a39e5112f3322
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TICRR ANLN SMC2 CDCA8 RAD21	4.65e-05	190	92	5	cd37ccd30c27cf65eda0a9165f35b7672f5acaf6
ToppCell	COVID-19-kidney-Proliferating_T_cell\|COVID-19 / Disease (COVID-19 only), tissue and cell type	TICRR ANLN SMC2 LCP1 CDCA8	4.77e-05	191	92	5	bae388e0e9447d576e68465d73d8313ef6925ffa
ToppCell	PND01-03-samps-Mesenchymal-Matrix_fibroblast-MatrixFB-A\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	MYLK DGKB MACF1 OGN MAF	4.77e-05	191	92	5	e7c605b56934d1383237c1f946dbccef25d91368
ToppCell	Proliferating\|World / shred by cell class for mouse tongue	TICRR ANLN SMC2 CDCA8 RAD21	4.89e-05	192	92	5	f081f3f957cc782294e118fcc1055f6a4264ee98
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FNDC1 SVIL CMYA5 PFKP OGN	5.01e-05	193	92	5	7cd9671e0ac64f7f3607f564485c63abbb7e7a63
ToppCell	PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FNDC1 ANLN SMC2 CDCA8 RAD21	5.01e-05	193	92	5	a332dfdcc48c405020014e644aa4d14fda98cc86
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	MYOF FMO1 SVIL DGKB OGN	5.01e-05	193	92	5	cd45118ced91b10baed3b1068d4673ec99824b86
ToppCell	severe_influenza-RBC\|severe_influenza / disease group, cell group and cell class (v2)	KRT1 ANLN KCNH2 ARHGEF12 FBXO30	5.01e-05	193	92	5	ffb0b3c2cce13b6891157f0fede2600f3938670e
ToppCell	PND01-03-samps-Mesenchymal\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	MYLK DGKB MACF1 OGN MAF	5.14e-05	194	92	5	4f9bd0ded0dde1df885850714f29e73e992539a5
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	MYOF TSHZ3 MYLK OGN MAF	5.14e-05	194	92	5	5f5f0cdeacd5e1b28717d78dabdb9eb95f661e36
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TICRR ANLN POLE SMC2 CDCA8	5.14e-05	194	92	5	4c1d13d8cb6fb424655c67755ee6dbaf59d6b418
ToppCell	PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ANLN POLE SMC2 CDCA8 ADGRL4	5.14e-05	194	92	5	3a49c7c86036e09a8cd0114988380d04ad1a26fb
ToppCell	moderate-Epithelial-FOXN4+\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	ALMS1 ANLN FAM227A SMC2 UTRN	5.14e-05	194	92	5	dff3fb10372053951d41e0ccd41aac3ece6009bd
ToppCell	PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYLK DGKB MACF1 OGN MAF	5.26e-05	195	92	5	cbe518b465b4ef32797ae6b608219207c08493df
ToppCell	COVID-19-kidney-Proliferating_T_cell\|kidney / Disease (COVID-19 only), tissue and cell type	TICRR ANLN SMC2 LCP1 CDCA8	5.26e-05	195	92	5	7e05e56f8d0a7a052830c7db12b10dace7d10760
ToppCell	PND03-Mesenchymal-Mesenchymal_structural\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYLK DGKB MACF1 OGN MAF	5.26e-05	195	92	5	136b06b0931a69b1241101f68c01c44c70365fd9
ToppCell	facs-Lung-nan-3m-Endothelial\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FMO1 CALU ARHGEF12 UTRN ADGRL4	5.26e-05	195	92	5	7f9b7f15006610ad591063d90e90367bd6083c7f
ToppCell	PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ANLN POLE SMC2 CDCA8 ADGRL4	5.26e-05	195	92	5	5790b47b0e028e49b99bda8d6d9e80ac79208cdf
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COPA CALU PRRC2C ARHGEF12 FBXO30	5.39e-05	196	92	5	66d76249bd2770cdddff2c1fe59a016e95da2124
ToppCell	10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-F_2\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PRRC2C HSPH1 MACF1 LCP1 UTRN	5.39e-05	196	92	5	ea8eceacc5d5e1a22b77c31e7c45985dc7bb15de
ToppCell	facs-Bladder-nan-3m\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COPA CALU MACF1 DCTN1 UTRN	5.39e-05	196	92	5	44f5b1b474399c9316729155f2ea95a82ca66e30
ToppCell	critical-Epithelial-Ciliated\|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	C20orf96 FAM227A CFAP57 SAMD15 CCDC39	5.39e-05	196	92	5	27b855c6e1ae44f16db998cf0e81bd686b9cee7e
ToppCell	PND01-03-samps-Mesenchymal-Matrix_fibroblast\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	MYLK DGKB MACF1 OGN MAF	5.39e-05	196	92	5	54f4cf778f95a9ff662e5c7520916a25e605bf95
ToppCell	PND10-Mesenchymal\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FNDC1 MYLK CALU OGN MAF	5.39e-05	196	92	5	ace167a40adb7022b365be3c2b1cbd4ba963739a
ToppCell	PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYLK DGKB MACF1 OGN MAF	5.39e-05	196	92	5	2a885eed52f9b002c7995e11e450c7e8d7ae69e6
ToppCell	PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYLK DGKB MACF1 OGN MAF	5.39e-05	196	92	5	14246f00c90741a5f8683f377e22e3a7c99661b9
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COPA CALU PRRC2C ARHGEF12 FBXO30	5.39e-05	196	92	5	9bd4c146fc7555e32adfa393b3a07846eb826d25
ToppCell	facs-Bladder-nan-3m-Epithelial\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COPA CALU MACF1 DCTN1 UTRN	5.39e-05	196	92	5	c0e90d964baa2eb4fbd18a52379ccec5d3bf59a8
ToppCell	PSB-critical-LOC-Epithelial-Ciliated\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	C20orf96 FAM227A CFAP57 SAMD15 CCDC39	5.52e-05	197	92	5	6865f4831eb23794fb88a8649d48d497bbae3f44
ToppCell	5'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FNDC1 MYLK KCNH2 CALU OGN	5.52e-05	197	92	5	398a66c06df63567b176ab2cc85e27837e94d0d9
ToppCell	severe-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	AKAP9 PRRC2C MACF1 UTRN MAF	5.52e-05	197	92	5	57ebd552f10d6278623b52a3d484d4b91ae1d028
ToppCell	Control-Control-Lymphocyte-T/NK-NK_activated\|Control / Disease, condition lineage and cell class	EFCAB5 POLE MACF1 LCP1 UTRN	5.66e-05	198	92	5	76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7
ToppCell	PBMC_fresh-frozen\|World / Compartment, severity and other cell annotations on 10x 3' data (130k)	BPTF ARID1B PRRC2C EIF3K UTRN	5.66e-05	198	92	5	dcc223a0396b8b673e4ed8c6733ec6cd74e9a03a
ToppCell	severe-Myeloid-Immature_Neutrophils_2\|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	ANLN POLE PCLO SMC2 CDCA8	5.66e-05	198	92	5	844f534551483c89ef789d1cfeb4680e54f794b2
Computational	Genes upregulated in subsets of cells of a given type within various tumors	BPTF AKAP9 MACF1 UTRN	1.75e-04	49	62	4	GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN
Computational	Genes upregulated in subsets of cells of a given type within various tumors	BPTF AKAP9 PRRC2C UTRN	1.75e-04	49	62	4	GAVISH_3CA_MALIGNANT_METAPROGRAM_41_UNASSIGNED
Drug	radicicol; Up 200; 0.1uM; PC3; HG-U133A	KRT1 VPS13D SLK AKAP9 ZC3H13 HSPH1 SVIL ZFR	1.07e-06	195	90	8	449_UP
Drug	alpha-estradiol; Up 200; 0.01uM; MCF7; HT_HG-U133A_EA	CYP1A2 ELOA2 COPA KCNH2 TTLL4 OTUD4 UTRN ITPR1	1.11e-06	196	90	8	990_UP
Drug	Gabazine [105538-73-6]; Up 200; 10.8uM; MCF7; HT_HG-U133A	CLIP4 CYP1A2 MYLK COPA KCNH2 RBM19 ATP8A2 PCLO	1.29e-06	200	90	8	4820_UP
Drug	Pargyline hydrochloride [306-07-0]; Down 200; 20.4uM; HL60; HG-U133A	CYP1A2 ALMS1 COPA CALU HSPH1 ZFR CHD1L	1.09e-05	191	90	7	1418_DN
Drug	Cyanocobalamin [68-19-9]; Down 200; 3uM; MCF7; HT_HG-U133A	CYP1A2 VPS13D AKAP9 SMG7 ALMS1 PRRC2C ZFR	1.12e-05	192	90	7	3252_DN
Drug	Ticlopidine hydrochloride [53885-35-1]; Down 200; 13.4uM; MCF7; HT_HG-U133A	CYP1A2 MYOF VPS13D KCNH2 ZMYM3 DNMT3A ITPR1	1.24e-05	195	90	7	4155_DN
Drug	Clopamide [636-54-4]; Down 200; 11.6uM; MCF7; HT_HG-U133A	VPS13D POLR3D ELOA2 AKAP9 TTLL4 UTRN DNMT3A	1.33e-05	197	90	7	5402_DN
Drug	Alclometasone dipropionate [667634-13-2]; Down 200; 7.6uM; MCF7; HT_HG-U133A	MYOF VPS13D MYLK ZC3H13 OTUD4 DNMT3A IFNAR1	1.33e-05	197	90	7	6094_DN
Drug	(-)-Cinchonidine [485-71-2]; Up 200; 13.6uM; MCF7; HT_HG-U133A	LATS1 TTLL4 ARHGEF12 MSANTD2 OTUD4 UTRN NCS1	1.37e-05	198	90	7	2772_UP
Drug	Nifenazone [2139-47-1]; Up 200; 13uM; HL60; HG-U133A	VPS13D ACOT11 CALU TTLL4 DCTN1 TGM5 ITPR1	1.42e-05	199	90	7	1439_UP
Drug	Rilmenidine hemifumarate [54187-04-1]; Down 200; 8.4uM; MCF7; HT_HG-U133A	CYP1A2 VPS13D KCNH2 ZC3H13 OTUD4 MECP2 ZMYM3	1.47e-05	200	90	7	6512_DN
Drug	nocodazole	ACTL7A LATS1 AKAP9 EIF3K EVPL SMC2 DCTN1 ADGRL4 ITPR1 RAD21	1.90e-05	477	90	10	CID000004122
Drug	m-xylene	CYP1A2 AKAP9 ANLN LCP1	2.28e-05	42	90	4	CID000007929
Drug	phenothiazine	CYP1A2 FMO1 MYLK KCNH2	2.75e-05	44	90	4	CID000007108
Drug	ersentilide	KCNH2 RBM19	4.62e-05	3	90	2	CID000130400
Drug	Benzydamine	FMO1 KCNH2	9.22e-05	4	90	2	ctd:D001591
Drug	KT 5926	MYLK LCP1	9.22e-05	4	90	2	ctd:C063769
Drug	Monobenzone [103-16-2]; Down 200; 20uM; MCF7; HT_HG-U133A	CLIP4 VPS13D SMG7 COPA OTUD4 DNMT3A	9.67e-05	186	90	6	3391_DN
Drug	carmustine; Up 200; 100uM; PC3; HT_HG-U133A	SMG7 ALMS1 HSPH1 ZFR UTRN NCS1	9.96e-05	187	90	6	6883_UP
Drug	disulfoton	FMO1 ATP8A2 DCTN1	9.99e-05	23	90	3	CID000003118
Drug	Neostigmine bromide [114-80-7]; Down 200; 13.2uM; PC3; HT_HG-U133A	BPTF PRRC2C PCLO ZFR UTRN RAD21	1.03e-04	188	90	6	6735_DN
Drug	Flupentixol dihydrochloride cis-(Z) [2413-38-9]; Down 200; 7.8uM; HL60; HT_HG-U133A	AKAP9 COPA CALU PRRC2C ZFR RAD21	1.06e-04	189	90	6	1288_DN
Drug	Corynanthine hydrochloride [66634-44-4]; Down 200; 10.2uM; MCF7; HT_HG-U133A	POLR3D SMG7 ALMS1 ARHGEF12 MACF1 ZFR	1.12e-04	191	90	6	4811_DN
Drug	Piperine [94-62-2]; Down 200; 14uM; MCF7; HT_HG-U133A	MYOF CALU TTLL4 MACF1 ZFR MECP2	1.15e-04	192	90	6	4830_DN
Drug	Fenoprofen calcium salt dihydrate [53746-45-5]; Down 200; 7.2uM; MCF7; HT_HG-U133A	COPA CALU PCLO ZFR CHD1L UTRN	1.22e-04	194	90	6	4736_DN
Drug	Josamycin [16846-24-5]; Up 200; 4.8uM; HL60; HG-U133A	VPS13D SMG7 COPA CALU UTP11 UTRN	1.22e-04	194	90	6	2034_UP
Drug	Dibucaine [85-79-0]; Down 200; 11.6uM; MCF7; HT_HG-U133A	MYOF LATS1 SMG7 ACOT11 KCNH2 RBM19	1.22e-04	194	90	6	4149_DN
Drug	Ascorbic acid [50-81-7]; Up 200; 22.4uM; HL60; HG-U133A	VPS13D CALU PRRC2C ZC3H13 CHD1L SMC2	1.22e-04	194	90	6	1610_UP
Drug	Nefopam hydrochloride [23327-57-3]; Down 200; 13.8uM; HL60; HT_HG-U133A	SMG7 SVIL ARHGEF12 MACF1 ZFR MECP2	1.25e-04	195	90	6	2355_DN
Drug	Zoxazolamine [61-80-3]; Down 200; 23.8uM; HL60; HT_HG-U133A	VPS13D POLR3D COPA CALU SVIL CHD1L	1.25e-04	195	90	6	1270_DN
Drug	Metaraminol bitartrate [33402-03-8]; Down 200; 8.6uM; MCF7; HT_HG-U133A	CYP1A2 VPS13D MYLK SMG7 PPP1R37 ZFR	1.25e-04	195	90	6	4692_DN
Drug	Tribenoside [10310-32-4]; Down 200; 8.4uM; MCF7; HT_HG-U133A	SMG7 COPA ACOT11 OTUD4 MECP2 DNMT3A	1.29e-04	196	90	6	5429_DN
Drug	Amyleine hydrochloride [532-59-2]; Down 200; 14.8uM; HL60; HG-U133A	CYP1A2 SMG7 UTP11 SMC2 CDCA8 MECP2	1.32e-04	197	90	6	1991_DN
Drug	Lynestrenol [52-76-6]; Down 200; 14uM; HL60; HG-U133A	CYP1A2 VPS13D ALMS1 ACOT11 MACF1 CHD1L	1.32e-04	197	90	6	2037_DN
Drug	Antazoline hydrochloride [2508-72-7]; Down 200; 13.2uM; HL60; HG-U133A	CYP1A2 ALMS1 CALU ARHGEF12 CDCA8 ITPR1	1.32e-04	197	90	6	1556_DN
Drug	Clindamycin hydrochloride [21462-39-5]; Down 200; 8.6uM; PC3; HT_HG-U133A	MYOF AKAP9 SMG7 ALMS1 ZFR MECP2	1.32e-04	197	90	6	5815_DN
Drug	Methyldopate hydrochloride [2508-79-4]; Down 200; 14.6uM; MCF7; HT_HG-U133A	VPS13D ELOA2 RBM19 EVPL UTRN DNMT3A	1.32e-04	197	90	6	4986_DN
Drug	Tobramycin [32986-56-4]; Down 200; 8.6uM; HL60; HT_HG-U133A	MYOF COPA CALU SVIL UTRN NCS1	1.32e-04	197	90	6	2481_DN
Drug	Nalidixic acid sodium salt hydrate; Down 200; 14.6uM; MCF7; HT_HG-U133A	MYOF KCNH2 RBM19 MACF1 EVPL ITPR1	1.36e-04	198	90	6	2297_DN
Drug	Naloxone hydrochloride [357-08-4]; Down 200; 11uM; MCF7; HT_HG-U133A	CYP1A2 MYOF KCNH2 RBM19 PCLO ARHGEF12	1.36e-04	198	90	6	5243_DN
Drug	Gramine [87-52-5]; Down 200; 23uM; MCF7; HT_HG-U133A	VPS13D ALMS1 ACOT11 KCNH2 UTRN DNMT3A	1.36e-04	198	90	6	2799_DN
Drug	Erythromycin [114-07-8]; Down 200; 5.4uM; MCF7; HT_HG-U133A	VPS13D POLR3D MACF1 ZFR GPATCH8 DNMT3A	1.36e-04	198	90	6	1510_DN
Drug	Pralidoxime chloride [51-15-0]; Down 200; 23.2uM; MCF7; HT_HG-U133A	CYP1A2 VPS13D ELOA2 SMG7 ALMS1 KCNH2	1.36e-04	198	90	6	5383_DN
Drug	Nomifensine maleate [32795-47-4]; Down 200; 11.2uM; PC3; HT_HG-U133A	MYOF PCLO TTLL4 SVIL EVPL UTRN	1.36e-04	198	90	6	2062_DN
Drug	Troleandomycin [2751-09-9]; Up 200; 5uM; HL60; HG-U133A	MYOF VPS13D ALMS1 ACOT11 ZFR MECP2	1.36e-04	198	90	6	1965_UP
Drug	Sulfamethoxypyridazine [80-35-3]; Down 200; 14.2uM; MCF7; HT_HG-U133A	MYOF VPS13D POLR3D ZFR UTRN IFNAR1	1.36e-04	198	90	6	4733_DN
Drug	Trihexyphenidyl-D,L Hydrochloride [58947-95-8]; Down 200; 11.8uM; MCF7; HT_HG-U133A	MYOF RBM19 PCLO SVIL EVPL DNMT3A	1.36e-04	198	90	6	4133_DN
Drug	Asiaticoside [16830-15-2]; Down 200; 4.2uM; PC3; HT_HG-U133A	SLK POLR3D ARHGEF12 EVPL LCP1 ITPR1	1.36e-04	198	90	6	7244_DN
Drug	Benzydamine hydrochloride [132-69-4]; Up 200; 11.6uM; HL60; HG-U133A	VPS13D POLR3D CALU MACF1 SMC2 MECP2	1.40e-04	199	90	6	1552_UP
Drug	2-propylpentanoic acid; Down 200; 2000uM; MCF7; HG-U133A	ZC3H13 PPP1R37 EVPL ZFR GPATCH8 MECP2	1.40e-04	199	90	6	346_DN
Drug	Vinpocetine [42971-09-5]; Down 200; 11.4uM; PC3; HT_HG-U133A	VPS13D ALMS1 SVIL ARHGEF12 EVPL ITPR1	1.40e-04	199	90	6	5859_DN
Drug	Sulfameter [651-06-9]; Up 200; 14.2uM; MCF7; HT_HG-U133A	POLR3D ELOA2 MYLK COPA EVPL DNMT3A	1.40e-04	199	90	6	6212_UP
Drug	Benzonatate [104-31-4]; Up 200; 6.6uM; MCF7; HT_HG-U133A	CYP1A2 SMG7 ALMS1 RBM19 ZFR ITPR1	1.40e-04	199	90	6	1679_UP
Drug	Khellin [82-02-0]; Up 200; 15.4uM; PC3; HG-U133A	CLIP4 VPS13D ACOT11 TTLL4 UTRN NCS1	1.44e-04	200	90	6	1922_UP
Drug	Urosiol [128-13-2]; Down 200; 10.2uM; MCF7; HT_HG-U133A	VPS13D AKAP9 SMG7 CALU RBM19 CHD1L	1.44e-04	200	90	6	6484_DN
Drug	celecoxib; Up 200; 10uM; MCF7; HG-U133A	VPS13D GSPT2 SMG7 UTP11 HSPH1 NCS1	1.44e-04	200	90	6	377_UP
Drug	Naproxen [22204-53-1]; Up 200; 17.4uM; HL60; HT_HG-U133A	MYOF MYLK OTUD4 MECP2 NCS1 TGM5	1.44e-04	200	90	6	1869_UP
Drug	oxybutynin	MYLK ATP8A2 NCS1	1.82e-04	28	90	3	CID000004634
Disease	endometrial cancer (is_implicated_in)	CYP1A2 POLE RAD21	1.82e-04	36	90	3	DOID:1380 (is_implicated_in)
Disease	Congenital long QT syndrome	AKAP9 KCNH2	4.97e-04	11	90	2	cv:C1141890
Disease	kidney cancer (implicated_via_orthology)	LATS1 POLE	4.97e-04	11	90	2	DOID:263 (implicated_via_orthology)
Disease	loneliness measurement	BPTF FNBP4 MACF1 UTRN	5.74e-04	124	90	4	EFO_0007865
Disease	Long QT syndrome	AKAP9 KCNH2	5.95e-04	12	90	2	cv:C0023976
Disease	MAP kinase-activated protein kinase 3 measurement	ZC3H13 LCP1	7.02e-04	13	90	2	EFO_0008226
Disease	N-acetylmethionine measurement	ALMS1 ITPR1	9.41e-04	15	90	2	EFO_0021427
Disease	Schizoaffective disorder-bipolar type	PCLO RAD21	1.07e-03	16	90	2	EFO_0009965
Disease	Romano-Ward Syndrome	AKAP9 KCNH2	1.07e-03	16	90	2	C0035828
Disease	coffee consumption, cups of coffee per day measurement	EFCAB5 CYP1A2	1.07e-03	16	90	2	EFO_0004330, EFO_0006782
Disease	Malignant neoplasm of endometrium	POLE RAD21	1.36e-03	18	90	2	C0007103
Disease	Carcinoma in situ of endometrium	POLE RAD21	1.36e-03	18	90	2	C0346191
Disease	Brugada Syndrome (disorder)	AKAP9 KCNH2	2.43e-03	24	90	2	C1142166
Disease	response to methotrexate, drug-induced liver injury	ATP8A2 ARHGEF12	2.85e-03	26	90	2	EFO_0004228, GO_0031427
Disease	Neurodevelopmental Disorders	ARID1B MECP2 ITPR1	2.92e-03	93	90	3	C1535926
Disease	peripheral arterial disease, traffic air pollution measurement	TSHZ3 MACF1 UTRN MAF	2.98e-03	194	90	4	EFO_0004265, EFO_0007908

Protein segments in the cluster

Peptide	Gene	Start	Entry
INKTLTKIRSIKEPV	ADGRL4	126	Q9HBW9
TLVLKKPTQEVKRIS	FAM227A	381	F5H4B4
EKKRSPQDVEVLKTT	AKAP9	2661	Q99996
KLKDEVLKETVSQRP	DCTN1	1201	Q14203
TAEKPKVKEIIDERT	DNMT3A	461	Q9Y6K1
RKKQLSEAKTEEPTV	CFAP36	176	Q96G28
AITQKEEIHRKKTVP	ALMS1	3431	Q8TCU4
TKVKLKQITPRTEEE	ACOT11	156	Q8WXI4
PEESKERLGKIVSKI	CALU	66	O43852
KQRRKITSKDIVTPE	ARID1B	1691	Q8NFD5
IRVILKTSKPKDVDA	CLIP4	166	Q8N3C7
KIIPENDIKSLTVKE	BPTF	1571	Q12830
KQEETPVLTRIEKQK	CECR2	316	Q9BXF3
VSPLQKSEIVDVVKK	ATP8A2	796	Q9NTI2
RESPTDKKQKVERIA	ARHGEF12	26	Q9NZN5
SKETEEQKPKLERVT	CCDC39	786	Q9UFE4
DEIPVTKRTLKIKQE	MSANTD2	256	Q6P1R3
PKKKRSVVLDEILEQ	RBM19	931	Q9Y4C8
PKRTIQSLKEKTEKV	OTUD4	981	Q01804
LEPIDITVKETKAKR	RAD21	306	O60216
KPEIQRKIQKELDTV	CYP1A2	336	P05177
IPDVSKRTKSKIQRE	ANO6	856	Q4KMQ2
KERTKLITPQVAKLE	PATL1	456	Q86TB9
VEKLQVRLATKTEPK	ELOA2	11	Q8IYF1
KKKILSSVVAETQRP	C20orf96	266	Q9NUD7
RQVKPKTVSEEERKV	MYLK	931	Q15746
EVKKEPVETDRIISQ	MAF	31	O75444
SKLKPEVVEELTRKT	NCS1	6	P62166
RKKAKEPTTQITEEV	ITPR1	1906	Q14643
EKKQITTSPITVRKN	LATS1	606	O95835
TTSPITVRKNKKDEE	LATS1	611	O95835
SLKVTSDPKVEQKIE	ANLN	531	Q9NQW6
KLTKKVRPQEVSETE	CFAP57	1166	Q96MR6
QDPVVRAQEIKTKIK	HSPH1	776	Q92598
PKIKERTHNVTEKVT	KCNH2	361	Q12809
TPLKSAKTRKVIQVD	CDCA8	106	Q53HL2
EEKEEIRKSKSVIVP	GSPT2	181	Q8IYD1
KIQSRKVERKPSVSE	GPATCH8	1096	Q9UKJ3
ERKIIEKKTDVTVPN	IFNAR1	381	P17181
KAEQAPTVKRTETEK	PCLO	1011	Q9Y6V0
RTVPKVEVKTTDKCI	PCLO	2731	Q9Y6V0
VPDTIDERTINKKKL	LCP1	171	P13796
PEIQKVKSREREQIK	KRT1	171	P04264
KPITSEKIKELVVTQ	PFKP	281	Q01813
KTVSKEVVRHEKDPV	EVPL	1311	Q92817
TEKTKVEEEVKTRKP	FAM153A	271	Q9UHL3
NIKEKETVIIPNEKS	OGN	56	P20774
PTVQRVKRDEKEQIK	KRT82	111	Q9NSB4
EDLVKVRKEISPAVK	POLE	161	Q07864
SAVKTEKTPQEKLRE	MACF1	3316	Q9UPN3
REPKKEAVKSFIETQ	PPP1R37	426	O75864
KKKLEPQTVEERSSV	OBSCN	1991	Q5VST9
TQVEKKKVLTEADTP	EFCAB5	191	A4FU69
VETERKKLPKETLEQ	COPA	1066	P53621
VDPVLEKQKKVVASR	FNDC1	281	Q4ZHG4
KKAPITEDVRVATQK	CMYA5	3321	Q8N3K9
KVFIRPSIKEVKENS	FMO1	296	Q01740
RVKAEVATELPKKTE	CHD1L	261	Q86WJ1
VSVPEERQSTVKKEK	DGKB	386	Q9Y6T7
SQEESIKPKNIVEKI	EIF3K	191	Q9UBQ5
VSPQDRTEEEIKKIL	EDDM13	66	A0A1B0GTR0
KFSKTIEKEISPEIR	EFCAB13	41	Q8IY85
KIRERDSKTSQVPVK	KCTD5	141	Q9NXV2
PASKVVVTRENDKKV	DCAF8L1	321	A6NGE4
KIKKLESVITAVEIP	HEATR1	736	Q9H583
RGKKQTIPSVEVEKI	EML5	1156	Q05BV3
TDKVSKPREQISVKS	FBXO30	146	Q8TB52
VEEKTQTKPTEKILE	SAMD15	391	Q9P1V8
VQETVLPIKKRKTRE	MECP2	296	P51608
LPIKKRKTRETVSIE	MECP2	301	P51608
IIKETKEEVTPEQLK	UTP11	81	Q9Y3A2
KPTSKQEEIVKRLVS	UTRN	1681	P46939
KTFTPNIISRKIKEE	POLR3D	56	P05423
NIISRKIKEEPKEEV	POLR3D	61	P05423
TTQIDKEKKEIPVSI	SLK	676	Q9H2G2
PSRVKVREKLVKEES	SVIL	301	O95425
KIKVQTTPKVEEEQD	FNBP4	511	Q8N3X1
EKPVVTFKENIKTRE	SMG7	541	Q92540
KQPEKVISKDLVIER	PRRC2C	1136	Q9Y520
TVRLTEAKPVDKVKL	MRPL12	131	P52815
KERPKQEVTKAVVVD	ACTL7A	61	Q9Y615
KLRDETEQPVSKVIE	TP53TG5	21	Q9Y2B4
PDQVKEIKTEGKRTI	PHF13	186	Q86YI8
IEIPKVSKRATKKEN	TICRR	876	Q7Z2Z1
TEAIKPSQKTREKEK	WASHC2C	1221	Q9Y4E1
KTLKEITEGKTVQIP	UCK2	96	Q9BZX2
EEKSSPEKILVNKII	TGM5	601	O43548
EEITPTIQKLKEERS	SMC2	201	O95347
SISPKLNVEVKKEVD	TSHZ3	461	Q63HK5
PVKRVRKAIEKSETT	ZNF644	1021	Q9H582
EVKPSIRARKIQEEK	ZFR	621	Q96KR1
KIKDVVVKTIISSEP	TTLL4	856	Q14679
KIVETIEELKVKIPS	ZMYM3	911	Q14202
IIIKKEVSPEVVRSK	ZC3H13	191	Q5T200
DVSPKTQRVILKKKE	VPS13D	3626	Q5THJ4
ERVESVVIKNLKKTP	MYOF	1336	Q9NZM1